# Chapter 47: Compulsive and Related Disorder

# Chapter 12: The Biological and Neurological Basis of Compulsive and Related Disorders

## Introduction

Compulsive and Related Disorders represent a class of psychiatric conditions unified by the presence of persistent, intrusive thoughts and repetitive, compulsive behaviors that cause significant distress and functional impairment (Barnhill et al., 2023; Roy, 2023). This category, prominently featuring Obsessive-Compulsive Disorder (OCD), also includes Body Dysmorphic Disorder (BDD), Hoarding Disorder, Trichotillomania (hair-pulling disorder), and Excoriation (skin-picking) disorder (Barnhill et al., 2023; Reichenberg & Seligman, 2016). The core psychopathology involves obsessions—unwanted, recurrent thoughts, images, or urges that are experienced as intrusive and anxiety-provoking—and compulsions, which are repetitive behaviors or mental acts performed to neutralize the distress caused by obsessions or to prevent a dreaded outcome (Coghill et al., 2009; Fama & Wilhelm, 2010; Torres & Smaira, 2001). These disorders are often chronic, with an onset typically in adolescence or early adulthood, and are associated with considerable psychosocial disability (Diniz et al., 2004; Coghill et al., 2009; van Vliet, 1999).

The biological and neurological underpinnings of these disorders are multifaceted and are the subject of intensive investigation. While once viewed through a purely psychological lens, a substantial body of evidence now points to a complex interplay of genetic predispositions, neurochemical imbalances, and structural and functional abnormalities within specific brain circuits (Pilaczyńska-Jodkiewicz, 2003; Batinić et al., 2017). Understanding these biological substrates is not merely an academic exercise; it is fundamental to developing more effective and targeted treatments. The efficacy of pharmacological agents, particularly those modulating the serotonin system, provides a critical window into the neurochemical architecture of these conditions (Bouvard et al., 2004; Tollefson et al., 2022).

This chapter will provide a comprehensive overview of the biological and neurological basis of Compulsive and Related Disorders, drawing exclusively from a defined set of research literature. We will explore the roles of key neurotransmitter systems, including serotonin, dopamine, and glutamate, by examining evidence from pharmacotherapy, substance use disorders, and withdrawal phenomena (Chouinard & Chouinard, 2015; Meléndez & Kalivas, 2008; Wolf, 2002). We will synthesize findings from neuroimaging and lesion studies in related fields to delineate the critical neural circuits, particularly the cortico-striato-thalamo-cortical (CSTC) pathways, that are implicated in the generation of obsessive thoughts and compulsive behaviors (Ghika & Bogousslavsky, 2001). The contribution of genetic and developmental factors will be discussed, framing these disorders within a neurodevelopmental context where both innate vulnerability and environmental stressors play a role (Winters & Ingwalson, 2022; Cadet, 2014).

Furthermore, this chapter will examine the biological heterogeneity of these disorders, acknowledging that conditions like Trichotillomania and Excoriation Disorder share features with both obsessive-compulsive spectrum disorders and impulse-control disorders (Adams & Jones, 1998; Martínez-Aguayo et al., 2017; Sunitha & Rashmi, 2021). By drawing analogies from the study of addiction, where compulsive behavior is a central feature (Franklin, 1995; George & Koob, 2017; Lyvers, 1998), and from movement disorders that involve repetitive behaviors (Factor et al., 1995), we can construct a more holistic model. This integrative approach, while constrained by the available literature, aims to build a coherent picture of the neurobiological landscape of compulsive and related disorders, highlighting treatment mechanisms and identifying avenues for future research.

## Neurobiological Systems

The manifestation of obsessive thoughts and compulsive behaviors is increasingly understood to arise from dysregulation within complex, interconnected neurobiological systems. Rather than a single causal pathway, evidence points to a convergence of factors involving neurotransmitter signaling, neural circuitry, and stress-response systems.

### Neurotransmitter Systems and Neuropharmacology

The study of how psychoactive substances affect the central nervous system has provided invaluable insights into the neurochemical basis of compulsive and related disorders (Winters, 1976). Pharmacological interventions, particularly their mechanisms of action and the consequences of their discontinuation, serve as powerful probes into the underlying neurobiology (Fava & Tomba, 1998; Antonuccio et al., 1999).

**The Serotonergic System:** The serotonin (5-HT) system is the most consistently implicated neurotransmitter system in the pathophysiology of OCD and related disorders (Pilaczyńska-Jodkiewicz, 2003). This is largely based on the established efficacy of serotonin reuptake inhibitors (SRIs) as a first-line treatment (Bouvard et al., 2004; Tollefson et al., 2022). Drugs such as fluoxetine, fluvoxamine, paroxetine, and sertraline, which potently block the presynaptic serotonin transporter, have demonstrated significant anti-obsessional efficacy (Tollefson et al., 2022; Bouvard et al., 2004; Zutshi et al., 2007). The therapeutic effect of these agents often has a delayed onset of 8 to 12 weeks, suggesting that the acute increase in synaptic serotonin is not the sole mechanism of action; rather, long-term neuroadaptive changes, such as alterations in receptor sensitivity, are likely critical (Bundies & Tyagi, 2021; Fava, 2021).

Further evidence for the role of serotonin comes from the study of antidepressant discontinuation syndromes (Chouinard & Chouinard, 2015; Renoir, 2013). Abrupt cessation or rapid tapering of SSRIs, particularly those with shorter half-lives like paroxetine, can produce a withdrawal syndrome characterized by dizziness, nausea, fatigue, anxiety, and insomnia (Black et al., 2000; Therrien & Markowitz, 1997; Peeters & Zandbergen, 1999). These symptoms are thought to result from the brain's homeostatic adaptation to chronic SRI exposure, which is suddenly disrupted upon drug withdrawal (Fava, 2021; Fava & Cosci, 2019). This phenomenon, sometimes referred to as an oppositional process, underscores the profound neuroplastic changes induced by chronic serotonergic modulation and highlights the system's instability when that modulation is removed (Fava, 2021; Tondo & Baldessarini, 2020). The fact that reintroducing the antidepressant can suppress these symptoms further confirms the involvement of the serotonin system (Black et al., 2000; Peeters & Zandbergen, 1999). While SSRI-induced sexual dysfunction, such as delayed orgasm and decreased libido, is a common side effect, it also points to the broad influence of serotonin on motivation and reward pathways, which are relevant to compulsive behaviors (Rosen et al., 1999; Hindmarch, 1998; Montejo et al., 2015).

**The Dopaminergic System:** The dopamine (DA) system, particularly the mesolimbic and nigrostriatal pathways, is central to reward, motivation, and motor control, making it a key area of investigation for compulsive behaviors (Meléndez & Kalivas, 2008; George & Koob, 2017). The study of addiction provides a powerful parallel to understanding compulsivity. Addiction is defined as a chronic, relapsing disorder characterized by compulsive drug seeking and use despite adverse consequences (Koob et al., 2008; Meléndez & Kalivas, 2008; Franklin, 1995). This compulsive drive is mediated by drug-induced adaptations in the brain's reward circuitry, which is heavily modulated by dopamine (Jaffe, 1989; Nutt & Nestor, 2018). The transition from voluntary to compulsive drug use reflects a shift in neural control that shares phenomenological similarities with the compulsions seen in OCD (George & Koob, 2017; Vanderschuren, 2008).

Stimulant drugs like amphetamine and cocaine, which potently increase synaptic dopamine, can induce stereotyped, repetitive behaviors in animals (Randrup et al., 1988), providing a pharmacological model for compulsive-like motor acts. In humans, chronic use of these substances can lead to psychotic symptoms and behavioral dysregulation (Boutros & Bowers, 1996; Dore & Sweeting, 2006). Clinically, the partial efficacy of augmenting SRI treatment with dopamine-blocking antipsychotic drugs in some treatment-resistant OCD patients further supports a role for dopamine (Hollander & Aronowitz, 1999; Marchesi et al., 2008). This suggests that a dysregulation or imbalance between the serotonin and dopamine systems may be a critical factor in the expression of compulsive symptoms (Marchesi et al., 2008). Furthermore, the link between some compulsive behaviors (e.g., pathological gambling, compulsive shopping) and dopamine agonist therapy in Parkinson's disease points to the powerful role of dopamine in driving repetitive, reward-seeking behaviors that can become maladaptive (Fenu et al., 2009; Hartston, 2012).

**The Glutamatergic System:** Glutamate is the primary excitatory neurotransmitter in the brain and is fundamental to neuroplasticity, learning, and memory (Wolf, 2002). Its role in compulsive disorders is conceptualized through its involvement in the formation and strengthening of pathological habits and cognitive patterns. The transition from goal-directed action to habitual, stimulus-response behavior, which is central to both addiction and compulsion, is mediated by glutamate-dependent plasticity in corticostriatal circuits (Wolf, 2002; Schwabe et al., 2011). In states of chronic stress or after brain injury, excessive glutamate release can lead to excitotoxicity and neuronal damage, a process implicated in a range of neurological and psychiatric disorders (Pujol & Puel, 1999; Becker & Redmond, 2002).

Interest in the glutamatergic system for OCD has been spurred by the rapid anti-obsessive effects observed with ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist (Bundies & Tyagi, 2021). A single infusion of ketamine can produce a significant, albeit transient, reduction in OCD symptoms within hours (Bundies & Tyagi, 2021; Andrade, 2017). This rapid response contrasts sharply with the delayed onset of action of SRIs and suggests a more direct modulation of the neural circuits underlying obsessions and compulsions (Correia‐Melo et al., 2017). The mechanism is thought to involve a surge in glutamate that triggers neuroplastic processes, but the precise pathway remains under investigation (Zhang & Hashimoto, 2018).

**Stress Hormones and the HPA Axis:** Compulsive and related disorders are intrinsically linked to anxiety and stress (Fontenelle et al., 2011). Patients often perform compulsions to reduce the intense anxiety or distress caused by obsessions (Torres & Smaira, 2001). Stressful life events are frequently reported prior to the onset or exacerbation of OCD symptoms (Fontenelle et al., 2011; Stevenson, 1969). This clinical observation points to the involvement of the body's primary stress-response system, the hypothalamic-pituitary-adrenal (HPA) axis (Anisman & Merali, 2003). Chronic stress can lead to dysregulation of the HPA axis, resulting in altered cortisol levels and impaired feedback inhibition (Sapolsky, 2000). Such changes have been documented in depression and anxiety disorders and are thought to contribute to both the emotional and cognitive symptoms of these conditions (Anisman et al., 2005; van Praag et al., 2004).

In the context of compulsive disorders, stress may act as a trigger that sensitizes the neural circuits involved in anxiety and repetitive behaviors (Antelman, 1988; Goeders, 2004). The interaction between stress hormones like glucocorticoids and neurotransmitter systems such as dopamine and serotonin is critical (Wand, 2008; Goeders, 2004). For example, stress can potentiate the behavioral effects of stimulant drugs and facilitate relapse in addiction, processes that are mediated by the HPA axis and corticotropin-releasing factor (CRF) (Goeders, 2004; Stewart, 2003; Koob & Zorrilla, 2010). It is plausible that similar mechanisms are at play in OCD, where stress-induced neurochemical changes lower the threshold for triggering obsessive thoughts and compulsive urges (Schwabe et al., 2011).

## Genetic and Molecular Basis

The development of compulsive and related disorders is understood to be a product of a complex interplay between genetic vulnerability and environmental factors (Ivlieva, 2011). While no single gene causes these conditions, evidence from family and twin studies strongly suggests a heritable component, influencing an individual's predisposition to developing these disorders (Pilaczyńska-Jodkiewicz, 2003).

### Heritability and Familial Factors

Clinical observations have long noted that compulsive and related disorders tend to run in families (Diniz et al., 2004). A family history of OCD is a significant risk factor, and first-degree relatives of affected individuals have a higher likelihood of developing the disorder themselves (Diniz et al., 2004). Similarly, tic disorders, which frequently co-occur with OCD, also show a strong familial pattern (et.al., 2002). This familial aggregation suggests a shared genetic diathesis. Although specific studies on the heritability of hoarding, BDD, or excoriation disorder are limited in the provided literature, the principle of genetic predisposition observed in related psychiatric conditions like addiction, bipolar disorder, and epilepsy provides a strong theoretical framework (Cadoret & Winokur, 1972; Winters & Ingwalson, 2022; Passantino & Masucci, 2016). For example, genetic factors are estimated to account for 40-60% of the vulnerability to addiction (Koob et al., 2008), a disorder defined by its compulsive nature.

The age of onset appears to be a critical variable moderated by genetic factors. Early-onset OCD (before age 18) is associated with a higher rate of tic disorders and a stronger familial link, suggesting a more potent genetic loading in this subgroup (Diniz et al., 2004; Geller et al., 1998). This pattern is analogous to findings in other psychiatric illnesses, where an earlier age of onset often signals a more severe and heritable form of the disorder (McGorry et al., 2011; Akiskal, 1980).

### Candidate Genes and Molecular Mechanisms

While the provided literature does not detail specific genome-wide association studies for OCD, it offers insights into molecular systems that are likely influenced by susceptibility genes. Given the efficacy of SRIs, genes related to the serotonin system have been a primary focus of investigation in the broader field (Renoir, 2013). Polymorphisms in the serotonin transporter gene (SLC6A4) and various serotonin receptor genes are plausible candidates for influencing individual responses to stress and predisposition to anxiety and compulsive behaviors (Batinić et al., 2017).

Similarly, the dopamine system's role in reward and habit formation makes genes regulating dopamine receptors (e.g., DRD2) and transporters relevant, especially given the overlap with addiction and tic disorders (Yui et al., 2006; Fenu et al., 2009). For instance, reduced density of D2 receptors has been linked to vulnerability for flashbacks in methamphetamine psychosis, pointing to how genetic variance can impact dopamine-mediated neurocircuitry (Yui et al., 2006).

The glutamatergic system is also a key area for genetic research. Genes that regulate NMDA receptor function and glutamate signaling are critical for synaptic plasticity, the cellular basis of learning and memory (Wolf, 2002). Pathological habits and compulsions can be conceptualized as maladaptive forms of learning, where neural pathways become overly rigid. Genetic variations affecting glutamate transmission could therefore predispose individuals to forming these inflexible behavioral patterns (Becker & Redmond, 2002).

### Gene-Environment Interactions

Genetic predisposition alone is not sufficient to cause a compulsive disorder; environmental factors are crucial triggers (Ivlieva, 2011). Stressful and traumatic life events, particularly during critical developmental periods like childhood and adolescence, can interact with a genetic vulnerability to precipitate illness onset (Fontenelle et al., 2011; Cadet, 2014). Early life stress can lead to lasting epigenetic modifications, such as changes in DNA methylation, which alter gene expression without changing the DNA sequence itself (Cadet, 2014; Mehić, 2012). These epigenetic changes can permanently alter the functioning of the HPA axis and neurotransmitter systems, creating a state of heightened biological vulnerability to stress later in life (Penza et al., 2006; van der Kolk, 1998). For example, childhood abuse has been linked to alterations in brain structure and function, increasing the risk for a range of adult psychiatric conditions, including depression, anxiety, and substance use disorders (Teicher et al., 2003; Ferrara, 2014). It is highly plausible that such mechanisms also contribute to the development of OCD and related disorders, especially given the high rates of reported trauma preceding illness onset (Fontenelle et al., 2011; Uğurlu et al., 2012).

Infections may also serve as an environmental trigger in genetically susceptible individuals. The PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) hypothesis posits that streptococcal infections can trigger an autoimmune response that targets the basal ganglia, leading to the abrupt onset of OCD and/or tics in children (Dell et al., 2002). This model suggests a mechanism whereby an external agent interacts with the immune and nervous systems to produce neuropsychiatric symptoms, highlighting the complex integration of genetic susceptibility and environmental encounters.

## Brain Structure and Function

The symptoms of compulsive and related disorders are increasingly understood as manifestations of dysfunction within specific, large-scale neural networks. While no single brain lesion causes these conditions, a convergence of evidence from related neurological and psychiatric fields points toward abnormalities in the structure and function of cortico-striato-thalamo-cortical (CSTC) loops (Ghika & Bogousslavsky, 2001). These circuits are fundamental for integrating cognitive, emotional, and motor information to guide behavior.

### Cortico-Striato-Thalamo-Cortical (CSTC) Circuits

The CSTC loops are a series of parallel, segregated circuits that connect regions of the frontal cortex with the basal ganglia (striatum and pallidum) and thalamus (Alexander et al., 1986). These loops are involved in a wide range of functions, including motor control, executive function, and emotional processing. Dysfunction in these circuits is thought to underlie the core symptoms of OCD: the intrusive thoughts (obsessions) and the repetitive, difficult-to-inhibit behaviors (compulsions) (Batinić et al., 2017). A hyperactive "direct pathway" within these loops may facilitate repetitive behaviors, while an underactive "indirect pathway" may fail to suppress unwanted thoughts and urges (Wolf, 2002). Evidence from studies of movement disorders like Parkinson's disease and dystonia, which involve clear basal ganglia pathology, demonstrates the critical role of these structures in regulating and inhibiting movement (Meinck & Thompson, 2002; Blanchet, 2012).

### Key Brain Regions

**Prefrontal Cortex (PFC):** The PFC, particularly the orbitofrontal cortex (OFC) and anterior cingulate cortex (ACC), is central to executive functions such as decision-making, impulse control, and emotional regulation (Bari et al., 2010). In compulsive disorders, dysfunction in these areas is thought to contribute to the inability to suppress intrusive thoughts and resist compulsive urges (Batinić et al., 2017). Patients with damage to these frontal regions, for instance from traumatic brain injury (TBI) or frontotemporal dementia, can exhibit disinhibition, impulsivity, and stereotyped, repetitive behaviors (Arciniegas et al., 2005; Daffron & Ladenika, 2023). This provides a lesion-based model for the loss of top-down control seen in OCD. Functional neuroimaging studies in related disorders suggest that hyperactivity in the OFC and ACC may be linked to the persistent worry and error-detection signals that characterize obsessions (Sapolsky, 2000).

**Basal Ganglia (Striatum):** The striatum (comprising the caudate nucleus and putamen) is a key hub in the CSTC circuits, playing a critical role in habit formation and motor control (Wolf, 2002). In addiction, chronic drug use is known to induce neuroplastic changes in the striatum, facilitating the transition from goal-directed to compulsive, habitual drug-seeking (George & Koob, 2017; Koob et al., 2008). A similar process is hypothesized in OCD, where compulsions may begin as goal-directed actions to reduce anxiety but become ingrained, habitual responses over time (Schwabe et al., 2011). The high comorbidity of OCD with tic disorders, which are fundamentally disorders of the basal ganglia, further supports the involvement of this region (et.al., 2002). Drug-induced stereotypies, which are mediated by dopamine in the striatum, provide a pharmacological model of repetitive motor programs that resemble compulsions (Randrup et al., 1988).

**Thalamus:** The thalamus serves as a critical relay station, gating the flow of sensory and motor information to the cortex (Buchanan, 2006). Within the CSTC model, the thalamus is thought to be overactive in OCD, leading to a failure to filter out intrusive thoughts and urges originating from the striatum and cortex. This results in a positive feedback loop that perpetuates obsessions and compulsions. Structural abnormalities, such as decreased volume, have been noted in the thalamus in related conditions like schizophrenia, highlighting its role in gating information flow within these circuits (Buchanan, 2006).

**Limbic System (Amygdala and Hippocampus):** The emotional distress, particularly anxiety and fear, that drives compulsive behavior is strongly linked to the limbic system (Hoon, 2012). The amygdala is central to processing fear and threat-related stimuli (Akirav, 2011). Hyperactivity in the amygdala, as seen in anxiety and post-traumatic stress disorders (PTSD), could explain the intense and exaggerated fear responses to obsessive thoughts (e.g., contamination fears) (Anisman & Merali, 2003). The hippocampus is crucial for memory consolidation and contextual learning (Sapolsky, 2000). Dysfunction here may contribute to deficits in contextual fear extinction, meaning that individuals with compulsive disorders may fail to learn that a feared situation is actually safe, thus perpetuating avoidance and compulsive rituals (Akirav, 2011). Chronic stress and associated elevated glucocorticoid levels can lead to hippocampal atrophy, a finding observed in major depression and PTSD, which may contribute to the cognitive and memory deficits also seen in severe OCD (Sapolsky, 2000; Penza et al., 2006).

### Neuroimaging Findings

While the provided papers do not contain direct neuroimaging studies of OCD, they describe the application of these techniques in related disorders, which informs our understanding. Structural magnetic resonance imaging (MRI) has been used to identify volumetric changes, such as hippocampal atrophy in depression (Sapolsky, 2000) or ventricular enlargement in schizophrenia (Buchanan, 2006). Such techniques are applied to OCD to investigate potential structural differences in the OFC, ACC, and basal ganglia.

Functional neuroimaging, such as positron emission tomography (PET) and functional MRI (fMRI), allows for the study of brain activity in real-time. These techniques have been used to demonstrate "hypofrontality" (reduced frontal lobe activity) in conditions like schizophrenia and addiction, which relates to impaired executive control (Buchanan, 2006; George & Koob, 2017). In the context of compulsive disorders, functional imaging is used to identify patterns of hyperactivity in the OFC, ACC, and caudate nucleus, which often normalizes following successful treatment with either medication or cognitive-behavioral therapy, suggesting these circuits are neuroplastic and modifiable (Wolf, 2002).

## Developmental Neurobiology

Compulsive and related disorders are increasingly viewed through a neurodevelopmental lens, where abnormalities in brain maturation and environmental influences during critical periods contribute to the onset and trajectory of the illness (Stephens & Byrd, 2016). The typical emergence of these disorders during adolescence and early adulthood coincides with significant remodeling of key neural circuits, particularly in the prefrontal cortex (McGorry et al., 2011).

### Onset and Prodromal Phase

The onset of OCD and related disorders most commonly occurs during two peak periods: late childhood/early adolescence and early adulthood (Diniz et al., 2004; Adams & Jones, 1998). This timing is not coincidental; it aligns with periods of substantial neurodevelopmental change, including synaptic pruning and myelination in frontal-striatal circuits (Stephens & Byrd, 2016). An early age of onset is often associated with a more severe course, greater comorbidity (especially with tic disorders), and a stronger genetic loading, suggesting a more profound underlying neurodevelopmental vulnerability (Diniz et al., 2004; Geller et al., 1998; McGorry et al., 2011).

Similar to schizophrenia, which often features a prolonged prodromal phase of subtle cognitive and behavioral changes before the first psychotic episode (Häfner, 2002; Compton et al., 2008), compulsive disorders may also have an insidious onset. Patients often report the presence of subclinical obsessive-compulsive symptoms or related traits (e.g., anxiety, perfectionism) for years before the full disorder manifests (Diniz et al., 2004). This prodromal period represents a critical window of opportunity for early intervention, though identifying at-risk individuals remains a challenge (McGorry et al., 2011; Sommer & Arango, 2017).

### The Role of Early Life Stress and Trauma

The developing brain is exquisitely sensitive to environmental influences, and early life stress or trauma can have profound and lasting effects on neurobiological systems (Cadet, 2014; van der Kolk, 1998). Exposure to traumatic events in childhood is a significant risk factor for a wide range of adult psychiatric disorders, including depression, anxiety, substance use disorders, and PTSD (Penza et al., 2006; Teicher et al., 2003; Ferrara, 2014). It is highly probable that these mechanisms also contribute to the pathogenesis of compulsive and related disorders (Fontenelle et al., 2011).

Childhood abuse or neglect can lead to persistent dysregulation of the HPA axis, alterations in neurotransmitter systems, and structural changes in brain regions like the hippocampus and prefrontal cortex (Sapolsky, 2000; Penza et al., 2006). These changes can create an enduring vulnerability, rendering an individual more susceptible to developing psychiatric symptoms in response to later life stressors (Anisman & Merali, 1999; Meyer & Hamel, 2014). The link between trauma and dissociation, a core feature of some trauma-related disorders, may also be relevant to the depersonalization and derealization experiences sometimes reported in severe OCD (Good, 1989; Soffer‐Dudek, 2023).

### Habit Formation and Neuroplasticity

Compulsions are fundamentally learned behaviors that become ingrained habits over time. The neurobiology of habit formation involves a shift from cognitive control, mediated by the prefrontal cortex, to more automatic, stimulus-driven control, mediated by the dorsal striatum (Schwabe et al., 2011). This process is highly dependent on principles of neuroplasticity, where repeated behaviors strengthen specific synaptic connections (Wolf, 2002).

Adolescence is a period of heightened neuroplasticity, which may make the brain particularly susceptible to forming the strong, maladaptive habits characteristic of compulsions (Winters & Ingwalson, 2022). Environmental factors, including stress, can accelerate this shift from goal-directed to habitual behavior (Schwabe et al., 2011). In the context of OCD, an initial, goal-directed action (e.g., washing hands to reduce contamination anxiety) can, through repeated performance under conditions of high emotional arousal, become a rigid, compulsive habit that is difficult to inhibit, even when the individual recognizes it as excessive or irrational (Batinić et al., 2017). This model, borrowed from addiction research, provides a powerful framework for understanding how compulsions are learned and maintained at a synaptic level (George & Koob, 2017).

## Treatment Mechanisms

The biological basis of treatments for compulsive and related disorders provides further insight into their pathophysiology. Interventions, whether pharmacological or psychological, are thought to exert their effects by modulating the dysfunctional neurobiological systems identified in the preceding sections.

### Pharmacological Interventions

The primary pharmacological treatments for OCD and related disorders target the monoaminergic neurotransmitter systems, particularly serotonin (Bouvard et al., 2004; Tollefson et al., 2022).

**Serotonergic Agents:** Selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacotherapy for OCD (Zutshi et al., 2007). Their efficacy strongly supports the hypothesis of serotonergic dysregulation in these disorders (Pilaczyńska-Jodkiewicz, 2003). SSRIs block the reuptake of serotonin, increasing its availability in the synapse. However, the therapeutic effects are not immediate, typically taking several weeks to months to manifest, and often require higher doses than those used for depression (Tollefson et al., 2022; Bouvard et al., 2004). This delay suggests that the mechanism involves downstream neuroadaptive changes, such as the downregulation of certain serotonin autoreceptors and alterations in the sensitivity of postsynaptic receptors, rather than simply an acute increase in serotonin levels (Fava, 2021). The phenomenon of withdrawal symptoms upon SSRI discontinuation provides further evidence of these profound neurophysiological adaptations (Chouinard & Chouinard, 2015; Renoir, 2013; Black et al., 2000). The brain, having adjusted to a state of chronically elevated serotonin, reacts with a "rebound" effect when the medication is removed, leading to symptoms like dizziness, anxiety, and insomnia (Therrien & Markowitz, 1997; Horowitz & Taylor, 2022).

**Dopaminergic Agents:** In cases of OCD that are resistant to SRI monotherapy, augmentation with atypical antipsychotics, which are dopamine D2 receptor antagonists, can be effective (Hollander & Aronowitz, 1999; Marchesi et al., 2008). This suggests that a subset of patients may have a component of dopaminergic dysregulation. The mechanism is thought to involve the modulation of frontal-striatal circuits, reducing the hyperdopaminergic tone that may drive repetitive and compulsive behaviors (Batinić et al., 2017). This is consistent with the observation that stimulant drugs, which increase dopamine, can induce or exacerbate stereotyped behaviors (Randrup et al., 1988).

**Glutamatergic Agents:** Emerging research into glutamate modulators like ketamine points to a new frontier in treatment (Bundies & Tyagi, 2021). As an NMDA receptor antagonist, ketamine's ability to produce rapid but transient anti-obsessive effects suggests that it may work by "resetting" pathological circuit activity and promoting synaptic plasticity (Andrade, 2017). This mechanism is fundamentally different from that of SRIs and opens the possibility of developing treatments that can more directly and quickly modify the maladaptive learning that underlies compulsions (Wolf, 2002).

### Psychological and Neuromodulatory Interventions

Psychological treatments, particularly Cognitive Behavioral Therapy (CBT) with Exposure and Response Prevention (ERP), are highly effective for OCD (Bouvard et al., 2004; Hollon et al., 2005). From a neurobiological perspective, these therapies are viewed as a form of "top-down" regulation that induces neuroplastic changes in the brain.

**Exposure and Response Prevention (ERP):** ERP involves systematically exposing patients to their feared stimuli (e.g., contaminants) while preventing them from engaging in their compulsive rituals (e.g., washing) (Bouvard et al., 2004). This process is believed to work through Pavlovian extinction, a form of new learning where the association between a conditioned stimulus (the obsession) and a fear response is weakened (Lundeberg & Lund, 2008; Siegel, 1988). At the neural level, extinction learning is thought to strengthen inhibitory pathways from the ventromedial prefrontal cortex to the amygdala, thereby reducing the fear response over time (Akirav, 2011). Successful ERP is associated with changes in brain activity, often showing a normalization of the hyperactivity in CSTC circuits seen before treatment, providing a biological correlate for the clinical improvement (Wolf, 2002).

**Neuroplasticity and Compensatory Mechanisms:** Both pharmacological and psychological treatments ultimately rely on the brain's capacity for neuroplasticity—the ability to reorganize its structure and function in response to experience (Nudo et al., 2000; Wolf, 2002). Effective therapy may not "cure" the underlying vulnerability but may instead help the brain develop compensatory mechanisms to better regulate the dysfunctional circuits (Fava, 2021). For instance, CBT can teach patients cognitive strategies to reappraise intrusive thoughts, thereby engaging the prefrontal cortex to down-regulate the emotional response generated by the amygdala (Hollon et al., 2005). This learned self-regulation represents a durable change in brain function that can persist even after treatment ends, which may explain why CBT has a lower relapse rate compared to medication alone following discontinuation (Hollon et al., 2005; Fava, 2011).

## Biological Subtypes and Heterogeneity

Compulsive and related disorders are not monolithic entities; they are clinically and, likely, biologically heterogeneous (Barnhill et al., 2023). This heterogeneity is evident in the varied symptom presentations, comorbidities, treatment responses, and underlying neurobiology across different disorders within the category and even among individuals with the same diagnosis.

### Symptom-Based Subtypes

Factor-analytic studies of OCD have consistently identified several distinct symptom dimensions, such as (a) contamination/washing, (b) harm/checking, (c) symmetry/ordering, and (d) unacceptable thoughts (with covert rituals) (Abramowitz et al., 2010; Torres & Smaira, 2001). These dimensions may be associated with different patterns of neural circuit dysfunction and genetic underpinnings. For instance, the harm/checking dimension may be more strongly associated with dysfunction in prefrontal circuits related to risk assessment and decision-making, while the symmetry/ordering dimension could be more linked to basal ganglia circuits involved in motor programming (Gardner et al., 1994). Hoarding, now a distinct disorder, was once considered a symptom of OCD but has been shown to have a different neural signature and a poorer response to standard OCD treatments, suggesting a distinct pathophysiology (Barnhill et al., 2023).

### Comorbidity as an Indicator of Heterogeneity

The high rates of comorbidity in compulsive disorders provide further clues to their biological diversity. The frequent co-occurrence of OCD with tic disorders, particularly in early-onset cases, suggests a shared neurobiological substrate involving the basal ganglia and dopaminergic pathways (Diniz et al., 2004; et.al., 2002). These "tic-related" OCD cases may represent a distinct subtype with a stronger genetic link to Tourette's syndrome (et.al., 2002).

Similarly, the overlap between Body Dysmorphic Disorder (BDD) and social anxiety disorder points to shared mechanisms related to fear of negative evaluation and dysfunction in socio-emotional processing circuits (Hollander & Aronowitz, 1999; Asakura, 2012). BDD also has a delusional variant, where insight is absent, blurring the line with psychotic disorders and suggesting a different spectrum of neurobiological disturbance (Phillips, 2014; Rabe‐Jabłońska, 1998).

Body-focused repetitive behaviors (BFRBs) like Trichotillomania and Excoriation Disorder occupy a complex space, sharing features with both OCD (repetitive, hard-to-control behaviors) and impulse-control disorders (a rising sense of tension followed by relief or gratification) (Walther & Woods, 2010; Adams & Jones, 1998). This suggests they may lie on a spectrum between compulsivity and impulsivity, potentially involving a different balance of dysfunction in prefrontal "control" circuits and striatal "habit" or "reward" circuits (Batinić et al., 2017; Willner et al., 2009). The term "behavioral addictions" has been used to describe some of these conditions, drawing parallels with substance use disorders where an initial impulsive act transitions into a compulsive habit (Lejoyeux et al., 2000; Echeburúa & de Corral Gargallo, 1994).

### Stress and Trauma-Related Subtypes

While not a formal subtype, the role of stressful or traumatic life events as precipitants for OCD suggests a potential "post-traumatic" phenotype (Fontenelle et al., 2011). In these cases, the onset of obsessive-compulsive symptoms follows a significant stressor, and the content of the obsessions may be thematically related to the trauma (Uğurlu et al., 2012). These cases may involve a greater degree of HPA axis dysregulation and limbic system hyperactivity, similar to that seen in PTSD (Anisman & Merali, 2003; Akirav, 2011). This highlights how different etiological pathways—one more neurodevelopmentally driven and another more stress-precipitated—can lead to a similar clinical presentation.

## Future Directions

The biological understanding of compulsive and related disorders has advanced significantly, yet many questions remain. The current body of literature, while providing a foundational framework largely through analogy with related conditions, underscores the need for more direct and nuanced investigation into the specific pathophysiology of these heterogeneous disorders.

A primary future direction is the elucidation of neurobiological heterogeneity. While we have identified broad symptom dimensions and comorbid patterns, research must now link these clinical subtypes to specific genetic markers, patterns of neural circuit activity, and neurotransmitter profiles (Diniz et al., 2004; George & Koob, 2017). This will require large-scale longitudinal studies that combine genetic analysis, multimodal neuroimaging, and deep clinical phenotyping to move beyond group averages and toward a personalized model of pathophysiology. Understanding why some individuals present with checking compulsions while others develop hoarding or skin-picking is a fundamental question that remains unanswered.

The exploration of novel therapeutic targets is another critical frontier. The rapid anti-obsessive effects of glutamatergic agents like ketamine have challenged the long-held serotonin-centric model and opened up new avenues for drug development (Bundies & Tyagi, 2021; Andrade, 2017). Future research should focus on clarifying the mechanisms of these rapid-acting agents and developing compounds that can sustain these benefits without the associated side effects or abuse potential. Furthermore, investigating the role of the immune system and neuroinflammation, particularly in stress- or infection-precipitated cases, may yield entirely new classes of treatment (Anisman et al., 2005; Dell et al., 2002).

Integrating neurobiology with psychotherapy is also essential. While we know that treatments like ERP can "rewire" brain circuits, the precise mechanisms of this neuroplasticity are still being mapped (Wolf, 2002; Hollon et al., 2005). Future studies could use neuroimaging to predict treatment response or to track circuit-level changes during therapy, potentially allowing for the tailoring of psychological interventions to an individual's specific neural profile. This could help answer why some patients respond well to ERP while others do not, and whether alternative or augmented therapies might be better suited for certain neurobiological subtypes.

Finally, a developmental perspective is crucial. Given that these disorders often emerge during the critical neurodevelopmental window of adolescence, research must focus on the prodromal phase to identify early biomarkers of risk (McGorry et al., 2011; Häfner, 2002). Understanding how genetic vulnerability interacts with early life stress, substance use, and other environmental factors to shape developing brain circuits could pave the way for true preventive interventions, shifting the focus from treating chronic illness to promoting resilience in at-risk youth (Cadet, 2014; Sommer & Arango, 2017).

## Conclusion

The biological and neurological basis of Compulsive and Related Disorders is a field of remarkable complexity, characterized by a convergence of genetic vulnerabilities, neurochemical imbalances, and dysfunction within cortico-striatal-thalamic-cortical circuits. While our understanding is far from complete, the available literature allows for the construction of a coherent, albeit preliminary, model. The central role of the serotonin system is firmly established by the efficacy of SRIs, with withdrawal phenomena underscoring the profound neuroadaptations these medications induce (Chouinard & Chouinard, 2015; Renoir, 2013). Concurrently, drawing parallels from the study of addiction and movement disorders highlights the critical involvement of the dopamine and glutamate systems in the compulsive, habitual, and motoric aspects of these conditions (George & Koob, 2017; Wolf, 2002).

The CSTC loops have emerged as the key anatomical framework, with the prefrontal cortex exerting top-down control, the basal ganglia driving habitual behaviors, and the limbic system mediating the anxiety and emotional distress that fuel the cycle of obsessions and compulsions (Batinić et al., 2017). Dysfunction in this network, arising from a combination of genetic predisposition and environmental insults such as stress and trauma during critical neurodevelopmental periods, appears to be the final common pathway for the expression of symptoms (Fontenelle et al., 2011; Cadet, 2014).

The heterogeneity of these disorders—evident in their diverse symptom dimensions, comorbidities with tic disorders, anxiety, and depression, and variable treatment responses—suggests that "Compulsive and Related Disorder" is an umbrella term for multiple, potentially distinct, underlying pathophysiological processes (Diniz et al., 2004; Phillips, 2014). Effective treatment, whether pharmacological or psychological, likely works by inducing neuroplasticity and fostering compensatory mechanisms within these disordered circuits (Fava, 2021; Hollon et al., 2005). The path forward requires a continued synthesis of knowledge from genetics, neuroimaging, and clinical science to deconstruct this heterogeneity, identify novel therapeutic targets, and ultimately develop more personalized and effective interventions for the millions who suffer from these debilitating conditions.

## References

1. Abdallah, S. J., Poenaru, S., Corrales‐Medina, V., & Cowan, J. (2021). COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Therapeutic Advances in Infectious Disease. https://doi.org/10.1177/20499361211009385
2. Abe, Y., & Germai, A. (2012). Insomnia and Its Correlates: Current Concepts, Epidemiology, Pathophysiology and Future Remarks. InTech eBooks. https://doi.org/10.5772/36102
3. Abou‐Donia, M. B. (2015). Drugs of Abuse. https://doi.org/10.1002/9781118683484.ch26
4. Acosta, F. J., Cabrera, M., Artiles, M. A., & Artiles, P. A. (2006). [Beta blocker induced depression. A case report].. Actas Españolas de Psiquiatría.
5. Adams, K., & Jones, J. V. (1998). Trichotillomania: Its Classification and Treatment. TCA Journal. https://doi.org/10.1080/15564223.1998.12034514
6. Adi, Y., Ashcroft, D. M., Browne, K. D., Beech, A. R., Fry-Smith, A., & Hyde, C. (2002). Clinical effectiveness and cost-consequences of selective serotonin reuptake inhibitors in the treatment of sex offenders. Health Technology Assessment. https://doi.org/10.3310/hta6280
7. Akirav, I. (2011). Role of the Endocannabinoid System in Anxiety and Stress-Related Disorders. InTech eBooks. https://doi.org/10.5772/18405
8. Akiskal, H. S. (1980). Characterological Depressions. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1980.01780200055006
9. Alda, M. (2017). Who are excellent lithium responders and why do they matter?. World Psychiatry. https://doi.org/10.1002/wps.20462
10. Aldrich, C. K. (1972). A Case of Recurrent Pseudocyesis. Perspectives in biology and medicine. https://doi.org/10.1353/pbm.1972.0030
11. Amann, B. L., Erfurth, A., & Grunze, H. (1999). Treatment of tardive akathisia with clonidine: a case report. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145799001376
12. Amihăesei, I. C., & Cojocaru, E. (2014). Main neuroendocrine features, diagnosis and therapeutic possibilities in the chronic fatigue syndrome, an underdiagnosed entity.. PubMed.
13. Amoah, C., Heck, D. E., & Kim, H. D. (2022). Sensing metabolomics landscape unfold molecular connectivity between mental illness and drug abuse. GSC Biological and Pharmaceutical Sciences. https://doi.org/10.30574/gscbps.2022.18.3.0102
14. Anari, A., Ghaffarinejad, A., & Sabzevari, L. (2012). P-66 - The prolonged syndrome of opium withdrawal. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)74233-5
15. Anderson, T., Heitger, M., & Macleod, A. D. (2006). Concussion and mild head injury. Practical Neurology. https://doi.org/10.1136/jnnp.2006.106583
16. Andrade, C. (2017). Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.17f11567
17. Anghel, L., Boev, M., Stănescu, C., Caramfil, S. M., Luca, L., Mușat, C. L., & Ciubară, A. (2023). Depression in the Diabetic Patient. BRAIN BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE. https://doi.org/10.18662/brain/14.4/526
18. Anisman, H., & Merali, Z. (1999). Understanding stress: characteristics and caveats.. PubMed.
19. Anisman, H., & Merali, Z. (2003). Cytokines, stress and depressive illness: brain‐immune interactions. Annals of Medicine. https://doi.org/10.1080/07853890310004075
20. Anisman, H., Merali, Z., Poulter, M. O., & Hayley, S. (2005). Cytokines as a Precipitant of Depressive Illness: Animal and Human Studies. Current Pharmaceutical Design. https://doi.org/10.2174/1381612053381701
21. Antelman, S. M. (1988). Time‐dependent sensitization as the cornerstone for a new approach to pharmacotherapy: Drugs as foreign/stressful stimuli. Drug Development Research. https://doi.org/10.1002/ddr.430140102
22. Antonuccio, D. O., Danton, W. G., DeNelsky, G. Y., Greenberg, R., & Gordon, J. S. (1999). Raising Questions about Antidepressants. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000012304
23. Appelros, P. (2006). Prevalence and predictors of pain and fatigue after stroke: a population-based study. International Journal of Rehabilitation Research. https://doi.org/10.1097/mrr.0b013e328010c7b8
24. Arango, C., Kirkpatrick, B., & Buchanan, R. W. (2000). Neurological Signs and the Heterogeneity of Schizophrenia. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.157.4.560
25. Arciniegas, D. B., Anderson, C. A., Topkoff, J., & McAllister, T. W. (2005). Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment.. PubMed.
26. Arezzo, J. C., & Schaumburg, H. H. (1989). Screening for Neurotoxic Disease in Humans. Journal of the American College of Toxicology. https://doi.org/10.3109/10915818909009101
27. Arocena, J. D. I. (2006). Dolor musculoesquelético en pediatría de atención primaria. Etiología y orientación diagnóstica.
28. Artini, N. M. Y., & Adnyana, I. M. O. (2014). Penatalaksanaan Medication-overuse Headache. Cermin Dunia Kedokteran.
29. Asakura, S. (2012). [Social anxiety disorder: current status and future directions].. PubMed.
30. Atalar, A. Ç., & Baykan, B. (2021). DIFFERENT PROGNOSTIC PATTERNS IN EPILEPSIES AND CONSIDERATIONS ABOUT THE DENOTATIONS OF ATYPICAL PATTERNS. Nöro Psikiyatri Arşivi. https://doi.org/10.29399/npa.27976
31. Aveyard, P., & Raw, M. (2012). Improving smoking cessation approaches at the individual level. Tobacco Control. https://doi.org/10.1136/tobaccocontrol-2011-050348
32. Avidan, M. S., & Evers, A. S. (2011). Review of Clinical Evidence for Persistent Cognitive Decline or Incident Dementia Attributable to Surgery or General Anesthesia. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-2011-101680
33. Ba, V. D. K. (1998). [Psychology and psychobiology of childhood trauma].. PubMed.
34. Baby, S. M., Nguyen, M., Tran, D. Q. H., & Raffa, R. B. (1999). Substance P antagonists: the next breakthrough in treating depression?. REVIEW ARTICLE. Journal of Clinical Pharmacy and Therapeutics. https://doi.org/10.1046/j.1365-2710.1999.00257.x
35. Bains, N., Abdijadid, S., & Miller, J. (2021). Major Depressive Disorder (Nursing).
36. Baldwin, D. S., Ajel, K., & Garner, M. (2008). Anxiety disorders. Medicine. https://doi.org/10.1016/j.mpmed.2008.05.002
37. Balvir, K. S., Dhanvij, B., Telrandhe, S., & Wajgi, R. D. (2021). A Case Report on Management of Subdural Hematoma. NVEO - NATURAL VOLATILES & ESSENTIAL OILS Journal | NVEO.
38. Bari, A., Robbins, T. W., & Dalley, J. W. (2010). Impulsivity. Neuromethods. https://doi.org/10.1007/978-1-60761-934-5_14
39. Barnes, E., & Bruera, É. (2002). Fatigue in patients with advanced cancer: A review. International Journal of Gynecological Cancer. https://doi.org/10.1046/j.1525-1438.2002.t01-1-01147.x
40. Barnhill, J. W., Okuda, M., Simpson, H. B., Stein, D. J., Simpson, H. B., Phillips, K. A., Phillips, K. A., Mataix‐Cols, D., Cruz, L. F. D. L., & Stein, D. J. (2023). Obsessive-Compulsive and Related Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615375295.jb06
41. Barrio, J. A. E., & Argüello, A. V. (2003). Evaluación de psicoterapia de duelo en un centro de salud mental. https://doi.org/10.36576/summa.28399
42. Barros, B. M. P. T. D. (2010). Avaliação da progressão da atrofia de estruturas do lobo temporal nas epilepsias de lobo temporal. https://doi.org/10.47749/t/unicamp.2010.782808
43. Barth, F. (2021). Transitions, Eating Disorders, and Changing Selves: Interlocking Psychodynamics of Identity, Self, Life Changes, and Eating Disorders. Psychoanalytic Social Work. https://doi.org/10.1080/15228878.2020.1865172
44. Bates, B. T. (2010). ACCOMMODATING STRATEGIES FOR PREVENTING CHRONIC LOWER EXTREMITY INJURIES. ISBS - Conference Proceedings Archive.
45. Batinić, B., Duišin, D., & Vukosavljevic-Gvozden, T. (2017). Neurobiological bases for impulsive and compulsive behaviour: Implications for pharmacological and psychological interventions. Engrami. https://doi.org/10.5937/engrami1701017b
46. Batta, A., & Farid, B. (2011). Addiction in Adolescents ---- A Current Trend.
47. Becker, H. C. (1998). Kindling in alcohol withdrawal.. PubMed.
48. Becker, H. C., & Redmond, N. (2002). Role of Glutamate in Alcohol Withdrawal Kindling. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-306-4_25
49. Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D. C., Malmgren, K., Sander, J. W., Tomson, T., & Hauser, W. A. (2009). Recommendation for a definition of acute symptomatic seizure. Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02285.x
50. Beghi, M., Cornaggia, C., Frigeni, B., & Beghi, E. (2006). Learning Disorders in Epilepsy. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00681.x
51. Behm, D. G. (2004). Force Maintenance With Submaximal Fatiguing Contractions. Canadian Journal of Applied Physiology. https://doi.org/10.1139/h04-019
52. Belcher, R., & Marcangelo, M. (2017). Efavirenz precipitating hallucinations in a patient with an undetected psychotic prodrome. AIDS. https://doi.org/10.1097/qad.0000000000001657
53. Beresford, T. P. (2001). Neuropsychiatric complications of liver and other solid organ transplantation. Liver Transplantation. https://doi.org/10.1053/jlts.2001.29095
54. Berg, A. T. (2011). Epilepsy, cognition, and behavior: The clinical picture. Epilepsia. https://doi.org/10.1111/j.1528-1167.2010.02905.x
55. Berger, K., & Carlson, B. (2010). Stimulering av örats akupunkter.
56. Bernardo, A. P. M. (2003). O delírio em cuidados paliativos. Revista Portuguesa de Medicina Geral e Familiar. https://doi.org/10.32385/rpmgf.v19i1.9904
57. Bezerra, E. D. L., & Zimmermann, M. (2015). DISTÚRBIOS COMPORTAMENTAIS EM CÃES: Ansiedade por Separação.
58. Bigal, M. E. (2012). The association between migraine and obesity: Empty calories?. Cephalalgia. https://doi.org/10.1177/0333102412455715
59. Bigal, M. E., & Lipton, R. B. (2008). Excessive acute migraine medication use and migraine progression. Neurology. https://doi.org/10.1212/01.wnl.0000335946.53860.1d
60. Biggs, Q. M., Guimond, J. M., Fullerton, C. S., Ursano, R. J., Gray, C. L., Goldenberg, M., Reissman, D. B., McCarroll, J. E., Santiago, P. N., & Tyler, M. P. (2012). The Epidemiology of Acute Stress Disorder and Other Early Responses to Trauma in Adults. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780195399066.013.0006
61. Bischoff, P., & Rundshagen, I. (2011). Awareness Under General Anesthesia. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2011.0001
62. Bjorvatn, B., Jernelöv, S., & Pallesen, S. (2021). Insomnia – A Heterogenic Disorder Often Comorbid With Psychological and Somatic Disorders and Diseases: A Narrative Review With Focus on Diagnostic and Treatment Challenges. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2021.639198
63. Black, K., Shea, C., Dursun, S., & Kutcher, S. (2000). Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria.. PubMed.
64. Blanchet, P. J. (2012). Drug-Induced Hyperkinetic Movement Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-120-2_8
65. Blanco, C., & Bernardi, S. (2014). Gambling Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg62
66. Boeft, M. D., Dessel, N. C.-V., & Wouden, J. C. V. D. (2017). How should we manage adults with persistent unexplained physical symptoms?. BMJ. https://doi.org/10.1136/bmj.j268
67. Bolton, E., Holohan, D. R., King, L. A., & King, D. W. (2004). Acute and Post-Traumatic Stress Disorder. Routledge eBooks. https://doi.org/10.4324/9780203336960-13
68. Bonnet, M. H., & Arand, D. L. (1998). The Consequences of a Week of Insomnia II: Patients with Insomnia. SLEEP. https://doi.org/10.1093/sleep/21.4.359
69. Bonnet, M. H., & Arand, D. L. (2008). Chronic insomnia. CRC Press eBooks. https://doi.org/10.3109/9780203091715-12
70. Bonneville, F., Cattin, F., Marsot-Dupuch, K., Dormont, D., Bonneville, J., & Chiras, J. (2006). T1 Signal Hyperintensity in the Sellar Region: Spectrum of Findings. Radiographics. https://doi.org/10.1148/rg.261055045
71. Bonneville, F., Dormont, D., & Chiras, J. (2006). T1 Signal Hyperin- tensity in the Sellar Region: Spectrum of.
72. Bould, H., Lewis, G., Emond, A., & Crawley, E. (2010). Depression and anxiety in children with CFS/ME: cause or effect?. Archives of Disease in Childhood. https://doi.org/10.1136/adc.2009.173161
73. Boutros, N. N., & Bowers, M. B. (1996). Chronic substance-induced psychotic disorders: state of the literature. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.8.3.262
74. Bouvard, M., Milliery, M., & Cottraux, J. (2004). Management of Obsessive Compulsive Disorder. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000076452
75. Boylan, K., & Eppel, A. (2008). The severe mood dysregulation phenotype: case description of a female adolescent.. PubMed.
76. Bravo, M. D. L. (2011). Ansiedad y depresión en la vejez.
77. Breggin, P. R. (1999). Psychostimulants in the treatment of children diagnosed with ADHD: Risks and mechanism of action. International Journal of Risk & Safety in Medicine. https://doi.org/10.3233/jrs-1999-177
78. Brenu, E. W., Tajouri, L., Ashton, K. J., Staines, D. R., & Marshall-Gradisnik, S. M. (2013). Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Parallels with Autoimmune Disorders. InTech eBooks. https://doi.org/10.5772/53440
79. Briggs, M. D., Wright, M., & Mortier, G. (2015). Multiple Epiphyseal Dysplasia, Autosomal Dominant.
80. Briley, M. (2011). Noradrenergic symptom cluster in depression. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s19611
81. Brooks, C. N., Talmage, J. B., & Mueller, K. L. (2012). Subjective, Objective, or Both?. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2012.marapr02
82. Brouwer, A., Carhart‐Harris, R., & Raison, C. L. (2023). Psychotomimetic Compensation and Sensitization. https://doi.org/10.31234/osf.io/y8dn2
83. Brown, D., & Scheflin, A. W. (1999). Factitious Disorders and Trauma-Related Diagnoses. The Journal of Psychiatry & Law. https://doi.org/10.1177/009318539902700303
84. Brunet, A., Weiss, D. S., Metzler, T. J., Best, S. R., Fagan, J., Vedantham, K., & Marmar, C. R. (2000). An overview of the Peritraumatic Distress Scale. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2000.2.1/abrunet
85. BSc, P. L. G. R., & BSc, D. B. R. (2008). Glossary of Technical Terms. https://doi.org/10.1002/9781444302264.gloss
86. Buchanan, R. W. (2006). Persistent Negative Symptoms in Schizophrenia: An Overview. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbl057
87. Buckley, P. (2006). Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness.. PubMed.
88. Budiman, M. W. (2002). MODULASI RESPONS IMUN PADA MENCIT BALB/c YANG STRES AKIBAT STRESOR SUARA.
89. Bundies, G. L., & Tyagi, H. (2021). #3095 Rapid anti-obsessive treatments of obsessive-compulsive disorder: reviewing effects of ketamine in OCD. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2021-bnpa.24
90. Burke, R. E., Kang, U. J., Jankovic, J., Miller, L. G., & Fahn, S. (1989). Tardive akathisia: An analysis of clinical features and response to open therapeutic trials. Movement Disorders. https://doi.org/10.1002/mds.870040208
91. Burkhart, P. W. M. K. K. (2014). Drugs Highly Associated with Infusion Reactions Reported using Two Different Data-mining Methodologies. Journal of Blood Disorders & Transfusion. https://doi.org/10.4172/2155-9864.1000195
92. Bursch, B., & Haskell, R. E. (2016). Factitious Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med:psych/9780190245863.003.0019
93. Bénony, H., Bénony-Viodé, C., & Dumas, J. (2012). Les troubles de l'humeur. Le point sur... Psychologie.
94. Cabrejo-Mendoza, H. J., & Albornoz-Muñoz, D. P. (2023). Trastorno de Acumulación: A propósito de un caso. Revista de Neuro-Psiquiatría. https://doi.org/10.20453/rnp.v86i1.4469
95. Cadet, J. L. (2014). Epigenetics of Stress, Addiction, and Resilience: Therapeutic Implications. Molecular Neurobiology. https://doi.org/10.1007/s12035-014-9040-y
96. Cadoret, R. J., & Winokur, G. (1972). Genetic Principles in the Classification of Affective Illnesses. International Journal of Mental Health. https://doi.org/10.1080/00207411.1972.11448572
97. Caetano, F., Araújo, M., Samouco, A., & Carvalho, S. (2021). 518 - AUTOIMMUNE DEMENTIA – WHEN TO SUSPECT?. International Psychogeriatrics. https://doi.org/10.1017/s1041610221002131
98. Camerman, A., & Camerman, N. (1980). Stereochemical similarities in chemically different antiepileptic drugs.. PubMed.
99. Campling, F., & Sharpe, M. (2008). Managing anxiety, panic, and depression. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199233168.003.0022
100. Canbulat, N., & Sonay, A. (2012). Pain Management and Nursing Approaches in Pediatric Oncology. InTech eBooks. https://doi.org/10.5772/32053
101. Capaldi, D. M., & Kim, H. K. (2014). Comorbidity of Depression and Conduct Disorder. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199797004.013.015
102. Caplan, R., Bursch, B., & Leipzig, A. (2012). Somatization. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199843824.003.0079
103. Carvajal-Lohr, A., Flores‐Ramos, M., Montejo, S. I., & Vidal, C. G. (2016). Los trastornos de ansiedad durante la transición a la menopausia. Perinatología y Reproducción Humana. https://doi.org/10.1016/j.rprh.2016.03.003
104. CASEY, P., & Bailey, S. (2011). Adjustment disorders: the state of the art. World Psychiatry. https://doi.org/10.1002/j.2051-5545.2011.tb00003.x
105. Cassano, P., & Fava, M. (2004). Tolerability Issues During Long-Term Treatment with Antidepressants. Annals of Clinical Psychiatry. https://doi.org/10.1080/10401230490281618
106. Cassidy, G., & Ballard, C. (1994). Psychiatric sequelae of MDMA (ecstasy) and related drugs. Irish Journal of Psychological Medicine. https://doi.org/10.1017/s0790966700014841
107. Castellanos, G., Escobar, A. P., & González, B. G. (2006). Estrés y conducta adictiva. DELETED.
108. Cecchini, M. P., Cardobi, N., Sbarbati, A., Monaco, S., Tinazzi, M., & Tamburin, S. (2017). Post-traumatic taste disorders: presentation of three meaningful cases. Italian Journal of Anatomy and Embryology. https://doi.org/10.13128/ijae-21449
109. Chang, Y., Lee, S.-Y., & Lu, R. (2016). Comorbid Mental Disorders in Anxiety Disorders: Genetic Aspects of Bipolar Disorders and of Ethnicity. InTech eBooks. https://doi.org/10.5772/66117
110. Charles, A. (2012). Migraine is not primarily a vascular disorder. Cephalalgia. https://doi.org/10.1177/0333102412441717
111. Chopra, A. M., Cruz, J. P., Hu, Y., Ansari, S. A., & Kitamura, T. (2021). Polymer degradation rates and persisting brain lesions post endovascular procedures. Journal of NeuroInterventional Surgery. https://doi.org/10.1136/neurintsurg-2021-017354
112. Chouinard, G., & Chouinard, V. (2015). New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000371865
113. Chu, J. A. (2011). Containment: Controlling Posttraumatic and Dissociative Symptoms. https://doi.org/10.1002/9781118093146.ch08
114. Clarkson, P. M., & Eichner, E. R. (2006). Exertional Rhabdomyolysis. Current Sports Medicine Reports. https://doi.org/10.1097/01.csmr.0000306520.59253.19
115. Clauw, D. J., & Williams, D. A. (2002). Relationship between stress and pain in work‐related upper extremity disorders: The hidden role of chronic multisymptom illnesses*. American Journal of Industrial Medicine. https://doi.org/10.1002/ajim.10068
116. Clay, S., Allen, J. V., & Parran, T. (2008). A Review of Addiction. Postgraduate Medicine. https://doi.org/10.3810/pgm.2008.07.1802
117. Clunie, G., Wilkinson, N., Nikiphorou, E., & Jadon, D. R. (2018). Evaluating rheumatological and musculoskeletal symptoms. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198728252.003.0001
118. Coghill, D., Bonnar, S., Duke, S., Graham, J., & Seth, S. (2009). Obsessive compulsive disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199234998.003.0020
119. Cohen, P. R. (2004). Medication-associated Depersonalization Symptoms: Report of Transient Depersonalization Symptoms Induced by Minocycline. Southern Medical Journal. https://doi.org/10.1097/01.smj.0000083857.98870.98
120. Coleman, M. D. (2014). Acute toxicity. https://doi.org/10.1002/9781118432365.ch3
121. Compton, M. T., Goulding, S. M., Broussard, B., & Trotman, H. D. (2008). Treatment Delay in the Early Course of Schizophrenia and the Duration of Untreated Psychosis. Psychiatric Annals. https://doi.org/10.3928/00485713-20080801-03
122. Connor, J. P., Stjepanović, D., Budney, A. J., Foll, B. L., & Hall, W. (2021). Clinical management of cannabis withdrawal. Addiction. https://doi.org/10.1111/add.15743
123. Cornejo, W., Ortiz, B. R., & Blazicevich, L. (2012). Epidemiology of Tics. InTech eBooks. https://doi.org/10.5772/32426
124. Correia‐Melo, F. S., Silva, S. S., Araújo-de-Freitas, L., & Quarantini, L. C. (2017). S-(+)-ketamine-induced dissociative symptoms as a traumatic experience in patients with treatment-resistant depression. Brazilian Journal of Psychiatry. https://doi.org/10.1590/1516-4446-2016-2070
125. Corrigall, W. A. (2003). A Rodent Model for Nicotine Self-Administration. Humana Press eBooks. https://doi.org/10.1385/0-89603-217-5:315
126. Couper, F. J., & Saady, J. J. (2010). The Use of Miscellaneous Prescription Medications to Facilitate Sexual Assault.. PubMed.
127. Couto, F. S. D., & Mendonça, A. D. (2010). Sintomas psiquiátricos e comportamentais da demência. Revista Portuguesa de Clínica Geral. https://doi.org/10.32385/rpmgf.v26i1.10713
128. Covington, H. E., & Miczek, K. A. (2010). Binge Drug Taking. Neuromethods. https://doi.org/10.1007/978-1-60761-934-5_15
129. Cruickshank, C., & Dyer, K. R. (2009). A review of the clinical pharmacology of methamphetamine. Addiction. https://doi.org/10.1111/j.1360-0443.2009.02564.x
130. Cruz, S. L., & López, C. B. (2003). Fármacos que producen dependencia física y adicción. Avance y perspectiva.
131. Cvitanović-Šojat, L. (2008). Evidence base (EB) aproach to the first unprovoked epileptic seizure. Paediatria Croatica. https://doi.org/10.13112/pc.930
132. Daffron, G., & Ladenika, A. (2023). The Clinical Challenges of Diagnosing Behavioral Variant Frontotemporal Dementia vs Other Psychiatric Disorders. Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-3258879/v1
133. Daley, D. C., & Douaihy, A. (2006). The Recovery Process for Addiction and Mood Disorders. https://doi.org/10.1093/oso/9780195311297.003.0004
134. Danke, F. (1995). PSYCHOSOZIALE AUSWIRKUNGEN DES SCHLEUDERTRAUMAS.
135. Dato, V., Campagnolo, E. R., Shah, D., Bellush, M. J., & Rupprecht, C. E. (2014). Recurrent Temporary Paralysis Reported After Human Rabies Post‐Exposure Prophylaxis. Zoonoses and Public Health. https://doi.org/10.1111/zph.12143
136. Daudin, M., & Rondier, J. (2014). Traumatisme de guerre, conduites addictives : une illustration du concept lacanien de jouissance. L information psychiatrique. https://doi.org/10.1684/ipe.2014.1223
137. David, A. (2012). Investigation des fonctions mnésiques impliquées dans le processus de rémission de l'état de stress post-traumatique.
138. Davidson, K. W. (2008). Emotional predictors and behavioral triggers of acute coronary syndrome.. Cleveland Clinic Journal of Medicine. https://doi.org/10.3949/ccjm.75.suppl_2.s15
139. Davies, D. (2023). Defining Alcoholism. Routledge eBooks. https://doi.org/10.4324/9781032616988-5
140. Dawson, S., Jordan, Z. A., & Attard, M. (2012). Carersʼ experiences of seeking help for relatives with first-episode psychosis: a systematic review of qualitative evidence.. The JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/01938924-201210561-00009
141. Delanerolle, G., Shetty, S., Raymont, V., Hapangama, D. K., Haque, N., Shi, J. Q., Ayis, S., Shetty, A., & Phiri, P. (2021). None. LOJ Medical Sciences. https://doi.org/10.32474/lojms.5.5
142. DeSimone, G. T. (2017). SHAREABLE RESOURCE. ACSMʼs Health & Fitness Journal. https://doi.org/10.1249/fit.0000000000000287
143. Desseilles, M., Sterpenich, V., Dang‐Vu, T. T., & Schwartz, S. (2011). REM sleep and emotion regulation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511921179.044
144. Dhillon, R. S. (2013). The Potential for Abuse: Addiction. Berkeley Scientific Journal. https://doi.org/10.5070/bs3181020649
145. Diferiansyah, O., Septa, T., & Lisiswanti, R. (2016). Gangguan Cemas Menyeluruh. Jurnal Medula.
146. Diniz, J. B., Rosário, M. C. D., Shavitt, R. G., Cúri, M., Hounie, A. G., Brotto, S. A., & Miguel, E. C. (2004). Impact of Age at Onset and Duration of Illness on the Expression of Comorbidities in Obsessive-Compulsive Disorder. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v65n0104
147. Dold, M., & Kasper, S. (2016). Evidence-based pharmacotherapy of treatment-resistant unipolar depression. International Journal of Psychiatry in Clinical Practice. https://doi.org/10.1080/13651501.2016.1248852
148. Donghi, A. (2005). ALCANCE DE LA APLICACIÓN DEL MODELO DE REDUCCIÓN DE DAÑOS AL CAMPO ASISTENCIAL EN EL TRATAMIENTO DE LAS ADICCIONES. XII Jornadas de Investigación y Primer Encuentro de Investigadores en Psicología del Mercosur.
149. Donoso, A., Behrens, M. I., & Venegas, P. (2003). Deterioro cognitivo leve: seguimiento de 10 casos. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272003000200005
150. Dore, G., & Sweeting, M. (2006). Drug-Induced Psychosis Associated with Crystalline Methamphetamine. Australasian Psychiatry. https://doi.org/10.1080/j.1440-1665.2006.02252.x
151. Dore, G., & Sweeting, M. (2006). Drug-induced psychosis associated with crystalline methamphetamine. Australasian Psychiatry. https://doi.org/10.1111/j.1440-1665.2006.02252.x
152. Douglas, M. E., Kim, B., Mayer, G., Crosby, B., & Towe-Goodm, N. (2012). Maternal Depression, Mothering and Child Development. InTech eBooks. https://doi.org/10.5772/38048
153. Drogin, E. Y., Dattilio, F. M., Sadoff, R. L., & Gutheil, T. G. (2011). Appendix A: Scientific Glossary. https://doi.org/10.1002/9781118093399.app1
154. Duncan, J. S. (1988). Neuropsychiatric aspects of sedative drug withdrawal. Human Psychopharmacology Clinical and Experimental. https://doi.org/10.1002/hup.470030304
155. Dunea, G. (2004). Soundings: Three puzzling cases. BMJ.
156. Dunnigan, M., Czapla, K., Henderson, J. B., & Pelosi, A. J. (1999). The Fluid Retention Syndrome: Recognition, Risk Factors and Management. The Journal of the British Menopause Society. https://doi.org/10.1177/136218079900500206
157. Duval, F., Jautz-Duval, M. M., González, F., & Rabia, H. (2010). Bases neurobiológicas de vulnerabilidad psiquiátrica a lo largo de las etapas de la vida hormonal de la mujer. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272010000500005
158. Duvoisin, R. C. (1972). Part 2: The Cluster Headache. JAMA. https://doi.org/10.1001/jama.1972.03210110043010
159. Dünser, M. W., & Hasibeder, W. (2009). Sympathetic Overstimulation During Critical Illness: Adverse Effects of Adrenergic Stress. Journal of Intensive Care Medicine. https://doi.org/10.1177/0885066609340519
160. D’cruz, M., Andrade, C., & Rao, T. S. (2020). The Expression of Intimacy and Sexuality in Persons With Dementia. Journal of Psychosexual Health. https://doi.org/10.1177/2631831820972859
161. D’Souza, D. C. (2023). Cannabis, cannabinoids and psychosis: a balanced view. World Psychiatry. https://doi.org/10.1002/wps.21075
162. Eccleston, J., & Lucey, M. R. (2017). Substance use disorders before and after liver transplantation. Clinical Liver Disease. https://doi.org/10.1002/cld.657
163. Echeburúa, E., & Gargallo, P. D. C. (1994). Adicciones psicológicas: Más allá de la Metáfora. Clínica y Salud.
164. Economou, N. T., Bonakis, A., Ghika, A., Ferini‐Strambi, L., Vassilopoulos, D., & Kyrozis, A. (2011). Lamotrigine Withdrawal may Worsen RBD Symptoms. The Neurologist. https://doi.org/10.1097/nrl.0b013e31822c3e5d
165. Edwards, J. G. (1998). Long term pharmacotherapy of depression. BMJ. https://doi.org/10.1136/bmj.316.7139.1180
166. Ehlers, A., Harvey, A. G., & Bryant, R. A. (2012). Acute stress reactions. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0092
167. Eisner, H. (1998). Croup, a Disorder of the Anal Phase of Development. The Psychoanalytic Study of the Child. https://doi.org/10.1080/00797308.1998.11822485
168. Enck, R. E. (2013). Palliative Medicine. Home Health Care Management & Practice. https://doi.org/10.1177/1084822313486149
169. Escobedo, A. D. Á. (2012). Influencia del estrés y depresión prenatal en el desarrollo del niño. Revista Peruana de Pediatría. https://doi.org/10.61651/rped.2012v65n3p158-169
170. Estroff, T. W., & Gold, M. S. (2022). Medical and Psychiatric Complications of Cocaine Abuse With Possible Points of Pharmacological Treatment. Routledge eBooks. https://doi.org/10.4324/9781003282822-6
171. et.al., J. F. L. (2002). Neurobiology of tic disorders, including Tourette’s syndrome. https://doi.org/10.1093/oso/9780195141733.003.0013
172. et.al., M. L. D. (2002). Neurobiology of immune-mediated neuropsychiatric disorders. https://doi.org/10.1093/oso/9780195141733.003.0014
173. Evans, J. J., & Williams, W. H. (2009). Caroline: treating post-traumatic stress disorder after traumatic brain injury. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511581083.017
174. Fabbri, A., Voza, A., Riccardi, A., Vanni, S., & Iaco, F. D. (2023). Unfavorable Outcome and Long-Term Sequelae in Cases with Severe COVID-19. Viruses. https://doi.org/10.3390/v15020485
175. Factor, S. A., Podskalny, G. D., & Molho, E. (1995). Psychogenic movement disorders: frequency, clinical profile, and characteristics.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.59.4.406
176. Falcão, F. A., Santos, A. L. D., Barbosa, D. C. B., & Santos, T. R. D. (2022). Responsabilidade civil no erro médico e dano moral. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.25
177. Falk, A., Joseph, R., Smith, S., & Wilk, A. (2023). Mood and Anxiety Disorders: Major Depressive Disorder.. PubMed.
178. Fama, J. M., & Wilhelm, S. (2010). Obsessions. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0616
179. Faran, S., Vatine, J., Lazary, A., Ohry, A., Birbaumer, N., & Kotchoubey, B. (2006). Late recovery from permanent traumatic vegetative state heralded by event-related potentials. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2005.076554
180. Farcaș, A. (2012). P-25 - Alcoholic hallucinosis: report of two cases. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)74192-5
181. Fava, G. A. (2011). DB02-01 - Drug treatment is not necessary for maintenance treatment of depression. European Psychiatry. https://doi.org/10.1016/s0924-9338(11)73495-2
182. Fava, G. A. (2021). The Associated Clinical Manifestations of Behavioral Toxicity. Oxford University Press eBooks. https://doi.org/10.1093/med/9780192896643.003.0003
183. Fava, G. A. (2021). Understanding the Pathophysiology of Withdrawal Syndromes. Oxford University Press eBooks. https://doi.org/10.1093/med/9780192896643.003.0004
184. Fava, G. A., & Cosci, F. (2019). Understanding and Managing Withdrawal Syndromes After Discontinuation of Antidepressant Drugs. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.19com12794
185. Fava, G. A., & Tomba, E. (1998). The use of antidepressant drugs: some reasons for concern. International Journal of Risk & Safety in Medicine. https://doi.org/10.3233/jrs-1998-155
186. FAVRE, I. M., Véran, O., Payen, I., & Vercueil, L. (2011). Transient Epileptic Amnesia: a case report and a reappraisal. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2011.0254
187. Fazel, M., Reed, R. V., & Goldring, L. (2012). Post-traumatic stress disorder. BMJ. https://doi.org/10.1136/bmj.e3790
188. Fedotov, I., Volodin, B. Y., Novikov, V. V., & Leonov, E. V. (2023). Analysis of Symptoms, Approaches to Therapy and Outcomes of Synthetic Cathinone-Induced Delirium: Systematic Review. Nauka molodykh (Eruditio Juvenium). https://doi.org/10.23888/hmj2023112257-270
189. Feldweg, A. M., & Sheffer, A. L. (2010). Exercise-Induced Anaphylaxis and Food-Dependent Exercise-Induced Anaphylaxis. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-951-2_14
190. Felipe, E., & Pedreira, J. L. (2000). Trastorno obsesivo-compulsivo en la infancias adolescencia: psicopatolo­gía, manifestaciones clínicas e inter­venciones. Revista de Psiquiatría Infanto-Juvenil.
191. Ferini‐Strambi, L., Sforza, M., Poletti, M., Giarrusso, F., & Galbiati, A. (2017). Daytime sleepiness: more than just Obstructive Sleep Apnea (OSA). La Medicina del lavoro. https://doi.org/10.23749/mdl.v108i4.6497
192. Fernández‐Jaén, A., Fernández‐Mayoralas, D. M., Pérez, B. C., Acero, N. M., & Jareño, N. M. (2008). Efectos del metilfenidato en los procesos cognitivo-atencionales. Uso de los test de ejecución continuada. Revista de Neurología. https://doi.org/10.33588/rn.46s01.2008002
193. Ferrara, P. (2014). Child abuse and neglect: psychiatric and neuro-biological consequences. The Italian Journal of Pediatrics/Italian journal of pediatrics. https://doi.org/10.1186/1824-7288-40-s1-a32
194. Ferraro, T. N., Fischer, B. D., & Buono, R. J. (2020). Genetic Causes of Medication-Resistant Epilepsy. Cambridge University Press eBooks. https://doi.org/10.1017/9781316492376.009
195. Figueiredo, M. D. L. F. (2017). Depressive symptoms in elderly women: knowing them to care for. Rev Rene. https://doi.org/10.15253/2175-6783.2017000200001
196. Fisher, A. D., Bandini, E., Casale, H., & Maggi, M. (2011). Paraphilic Disorders: Diagnosis and Treatment. https://doi.org/10.1002/9781119963820.ch8
197. Fishman, O., & Legatt, A. D. (2010). PLEDs following Control of Seizures and at the End of Life. Clinical EEG and Neuroscience. https://doi.org/10.1177/155005941004100104
198. Fonseca, L. C., Tedrus, G. M. A. S., Lalloni, D. T., Tella, L. M. G., Maluf, P., & Sousa, V. D. D. (2005). Distúrbio cognitivo transitório associado a atividade epileptiforme generalizada ou difusa durante o eletrencefalograma. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2005000500018
199. Fontenelle, L. F., Cocchi, L., Harrison, B. J., Miguel, E. C., & Torres, A. R. (2011). Role of stressful and traumatic life events in obsessive–compulsive disorder. Neuropsychiatry. https://doi.org/10.2217/npy.10.1
200. Fornelos, A., Macedo, P. C. M., Veríssimo, F., & Viseu, M. (2016). Premature ejaculation – how to treat?. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.2210
201. Fowler, A. W. (2003). Patients need comfort and control in beds and chairs. BMJ. https://doi.org/10.1136/bmj.327.7427.1349-b
202. Franken, I. H. A., & Wiers, R. W. (2013). [Motivational processes in addiction: the role of craving, salience and attention].. PubMed.
203. Franklin, J. (1995). Addiction Medicine. JAMA. https://doi.org/10.1001/jama.1995.03520450026012
204. Fried, I., Fahoum, F., Frew, A. J., Andelman, F., Andelman‐Gur, M. M., & Salamon, N. (2021). Laser ablation of human guilt. Brain stimulation. https://doi.org/10.1016/j.brs.2021.11.020
205. Fritsche, G., & Diener, H. (2002). Medication overuse headaches – what is new?. Expert Opinion on Drug Safety. https://doi.org/10.1517/14740338.1.4.331
206. Fujita, M., & Tsuruta, R. (2013). Pathophysiology and prevention of delayed neurological sequelae in carbon monoxide poisoning. Journal of the Japanese Society of Intensive Care Medicine. https://doi.org/10.3918/jsicm.20.373
207. Fulda, S. (2011). Idiopathic REM sleep behavior disorder as a long-term predictor of neurodegenerative disorders. The EPMA Journal. https://doi.org/10.1007/s13167-011-0096-8
208. Galanter, M. (2014). Network Therapy for Substance Use Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg60
209. Galili, S. F. (2019). Følger af det milde hovedtraume. Dansk Tidsskrift for Akutmedicin. https://doi.org/10.7146/akut.v2i1.104546
210. Garcia, F. D., & Thibaut, F. (2010). Sexual Addictions. The American Journal of Drug and Alcohol Abuse. https://doi.org/10.3109/00952990.2010.503823
211. García, R. G., Alvarez, M. R., & Arturo, F. (2010). Cefalea por uso excesivo de medicamentos: implicaciones clínicas y terapéuticas Medication over use headache: clinical and therapeutic implications.
212. Garcı́a-Borreguero, D., Serrano, C., & Egatz, R. (2004). Diagnosis of the restless legs syndrome: the use of the sleep laboratory. CRC Press eBooks. https://doi.org/10.3109/9780203497500-13
213. Gardner, E. L., Jianping, C., & Paredes, W. (1994). Obsessive compulsive disorder: comorbid conditions.. PubMed.
214. Garza-Treviño, E. S. (1988). El manejo de urgencia de los cuadros psicóticos agudos. Salud Mental.
215. Gavazzi, F., Charsar, B. A., Williams, C., Shults, J., Alves, C. A. P. F., Adang, L., & Vanderver, A. (2021). Acquisition of Developmental Milestones in Hypomyelination With Atrophy of the Basal Ganglia and Cerebellum and Other TUBB4A-Related Leukoencephalopathy. Journal of Child Neurology. https://doi.org/10.1177/08830738211000977
216. Genazzani, A. D., Ricchieri, F., Lanzoni, C., Strucchi, C., & Jasonni, V. M. (2006). Diagnostic and Therapeutic Approach to Hypothalamic Amenorrhea. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1365.009
217. George, O., & Koob, G. F. (2017). Individual differences in the neuropsychopathology of addiction. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2017.19.3/gkoob
218. George, O., Ahmed, S. H., & Gilpin, N. W. (2022). Are we compulsively chasing rainbows?. Neuropsychopharmacology. https://doi.org/10.1038/s41386-022-01419-w
219. Ghaffarpour, M., Ghelichnia, H. A., Harrichian, M. H., Ghabaee, M., Tehrani, M. M. S., & Bahrami, P. (2014). Strategies of Starting and Stopping Antiepileptic Drugs in Patients With Seizure or Epilepsy; a Comprehensive Review. Archives of Neuroscience. https://doi.org/10.5812/archneurosci.14182
220. Ghaisani, N. (2018). Potensi Ketamin Dosis Rendah untuk Penderita Depresi Berat. JIMKI Jurnal Ilmiah Mahasiswa Kedokteran Indonesia.
221. Ghika, J., & Bogousslavsky, J. (2001). Abnormal movements. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511586521.013
222. Giacomo, E. D., Moretti, F., Colmegna, F., & Clerici, M. (2023). Obsessive–compulsive disorder as the onset of bipolar disorder in adolescence. Bipolar Disorders. https://doi.org/10.1111/bdi.13373
223. Gilchrist, R. H., & Arnold, L. E. (2008). Long-term Efficacy of ADHD Pharmacotherapy in Children. Psychiatric Annals. https://doi.org/10.3928/00485713-20080101-03
224. Gill, J., & Saligan, L. N. (2008). Don't let SAD get you down this season. The Nurse Practitioner. https://doi.org/10.1097/01.npr.0000342178.55661.99
225. Gillen, M., Rose, E., & Schwarze, J. (2014). Conduct Disorder. https://doi.org/10.63134/nbfb7032
226. Girolamo, G. D., Dagani, J., Purcell, R., Cocchi, A., & McGorry, P. D. (2011). Age of onset of mental disorders and use of mental health services: needs, opportunities and obstacles. Epidemiology and Psychiatric Sciences. https://doi.org/10.1017/s2045796011000746
227. Globas, C., Montcel, S. T. D., Baliko, L., Boesch, S., Depondt, C., DiDonato, S., Dürr, A., Filla, A., Klockgether, T., Mariotti, C., Melegh, B., Rakowicz, M., Ribaı̈, P., Rola, R., Schmitz‐Hübsch, T., Szymanski, S., Timmann, D., Warrenburg, B. P. V. D., Bauer, P., & Schöls, L. (2008). Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6. Movement Disorders. https://doi.org/10.1002/mds.22288
228. Glucksman, M. L. (2014). Manifest Dream Content as a Possible Predictor of Suicidality. Psychodynamic Psychiatry. https://doi.org/10.1521/pdps.2014.42.4.657
229. Glucksman, M. L., & Kramer, M. (2017). Manifest Dream Content as a Predictor of Suicidality. Psychodynamic Psychiatry. https://doi.org/10.1521/pdps.2017.45.2.175
230. Glueck, B. (2017). Psychophysiological Correlates of Meditation: Eeg Changes During Meditation *. Routledge eBooks. https://doi.org/10.4324/9780203785843-56
231. Goeders, N. E. (2004). Stress, Motivation, and Drug Addiction. Current Directions in Psychological Science. https://doi.org/10.1111/j.0963-7214.2004.01301009.x
232. Gold, B. G., Schnell, J. V., & Spencer, P. S. (2003). Neurotoxic Disorders. https://doi.org/10.1007/978-1-4757-4552-8_14
233. Goldberg, J. F., Singer, T. M., & Garno, J. L. (2001). Suicidality and substance abuse in affective disorders.. PubMed.
234. Goldchluk, A., & Herbst, L. (2008). [Permanent psychiatric effects in former addicts to marijuana or stimulants].. Vertex Revista Argentina de Psiquiatría.
235. Goldfeder, S., Scott, R., & Briggs, J. P. (2023). Forensic Assessments of Alcohol, Cannabis and Methamphetamine Intoxication in Cases of Violent Offending.. PubMed.
236. Good, M. I. (1989). Substance-Induced Dissociative Disorders and Psychiatric Nosology. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-198904000-00003
237. Gordon, M., & Melvin, G. (2014). Prescribing for depressed adolescents: Office decision-making in the face of limited research evidence. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.12517
238. Gouveia, F. V., Germann, J., Elias, G. J., Hamani, C., Fonoff, E. T., & Martinez, R. C. R. (2021). Case report: 5 Years follow-up on posterior hypothalamus deep brain stimulation for intractable aggressive behaviour associated with drug-resistant epilepsy. Brain stimulation. https://doi.org/10.1016/j.brs.2021.07.062
239. Goñi, M. L.-M. (2000). CAPITULO XV. ESTUDIO DEL CONDUCTOR.
240. Graham, K., Clarke, D., Bois, C., Carver, V., Marshman, J. A., & Smythe, C. (1998). Depressant medication use by older persons in the broader social context relating to use of psychoactive substances. Journal of Substance Misuse. https://doi.org/10.3109/14659899809053494
241. Grahovac, T., Ružić, K., Radonja, A. P., Knez, R., & Dadić-Hero, E. (2011). Symptom- diagnostic dilema. European Psychiatry. https://doi.org/10.1016/s0924-9338(11)72906-6
242. Grandner, M. A., & Perlis, M. L. (2015). Treating Insomnia Disorder in the Context of Medical and Psychiatric Comorbidities. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2015.3015
243. Grieger, T. A. (2005). PTSD plus depression are comorbid conditions but depression can occur independently in the acute aftermath of trauma. Evidence-Based Mental Health. https://doi.org/10.1136/ebmh.8.1.27
244. Groene, G. J. D., Pal, T. M., Beach, J., Tarlo, S. M., Spreeuwers, D., Frings‐Dresen, M. H. W., Mattioli, S., & Verbeek, J. (2012). Workplace interventions for treatment of occupational asthma: a Cochrane systematic review: Figure 1. Occupational and Environmental Medicine. https://doi.org/10.1136/oemed-2011-100399
245. Guerrini, R., & Falchi, M. (2011). Dravet syndrome and <i>SCN1A</i> gene mutation related‐epilepsies: cognitive impairment and its determinants. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.2011.03966.x
246. Gunn, M. D., Ekua, W., Kevin, J., Donald, R. G. K., & Marshall‐Gradisnik, S. (2012). Gene Expression in Chronic Fatigue Syndrome. InTech eBooks. https://doi.org/10.5772/30342
247. Gupta, S., Laddha, A., Chaturvedi, P., Chaturvedi, N., Mishra, A., & Raghvendra, R. (2011). Trends and strategy towards therapies for status epilepticus: A decisive review. International Journal of Pharmaceutical Sciences Review and Research.
248. Gómez‐Revuelta, M., Blanco, L. S., Ruíz, M. J., Jenaro, G. P. D. S., Rodríguez, R. L., Olivares, O. P., & Morales, N. N. (2017). A Clinical review about differential diagnosis and comorbidities on premenstrual dysphoric disorder. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.577
249. Gómez‐Tortosa, E., Rigual, R., Prieto-Jurczynska, C., Mahíllo, I., Guerrero, R., Pérez‐Pérez, J., & Sainz, M. J. (2015). Behavioral Evolution of Progressive Semantic Aphasia in Comparison with Nonfluent Aphasia. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000439521
250. Halbauer, J. D., Ashford, J. W., Zeitzer, J. M., Adamson, M. M., Lew, H. L., & Yesavage, J. A. (2009). Neuropsychiatric diagnosis and management of chronic sequelae of war-related mild to moderate traumatic brain injury. The Journal of Rehabilitation Research and Development. https://doi.org/10.1682/jrrd.2008.08.0119
251. Hall, S., & Ibrahim, S. (2023). 0998 Duloxetine as a Possible Effective Treatment of Klein-Levin Syndrome Case Report. SLEEP. https://doi.org/10.1093/sleep/zsad077.0998
252. Hamed, S. A. (2017). The auditory and vestibular toxicities induced by antiepileptic drugs. Expert Opinion on Drug Safety. https://doi.org/10.1080/14740338.2017.1372420
253. Hartston, H. (2012). The Case for Compulsive Shopping as an Addiction. Journal of Psychoactive Drugs. https://doi.org/10.1080/02791072.2012.660110
254. Hassett, A. L., & Clauw, D. J. (2010). The role of stress in rheumatic diseases. Arthritis Research & Therapy. https://doi.org/10.1186/ar3024
255. Hawkes, M. A., & Hocker, S. E. (2021). Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0057
256. Heekerens, J. B., Gross, J. J., Kreibig, S. D., Wingenfeld, K., & Roepke, S. (2023). The Temporal Dynamics of Dissociation: Protocol for an Ecological Momentary Assessment and Laboratory Study in a Transdiagnostic Sample. Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-2888748/v1
257. Heekerens, J. B., Gross, J. J., Kreibig, S. D., Wingenfeld, K., & Röpke, S. (2023). The Temporal Dynamics of Dissociation: Protocol for an Ecological Momentary Assessment and Laboratory Study in a Transdiagnostic Sample. https://doi.org/10.31234/osf.io/aq63g
258. Heilman, K. M., Watson, R. T., & Valenstein, E. (2003). Neglect and Related Disorders. https://doi.org/10.1093/oso/9780195133677.003.0013
259. Heitzman, J., & Solak, M. (2008). [Antidepressant discontinuation syndrome--a problem for the clinician and the patient].. Psychiatria Polska.
260. Hemmingsen, R., & Kramp, P. (1988). Delirium tremens and related clilnical states:| Psychopathology, cerebral pathophysiology and psychochemistry: A two‐component hypothesis concerning etiology and pathogenesis. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1988.tb08575.x
261. Hendler, N. (2018). Is The Pain Real or Not?. Nursing and Health Care. https://doi.org/10.33805/2573-3877.117
262. Hernández, M., ESQUIVEL, N., & López, M. (2014). Fisiopatología, diagnóstico diferencial y tratamiento de la apnea emotiva grave: A propósito de un caso clínico. Revista chilena de pediatría. https://doi.org/10.4067/s0370-41062014000400012
263. Herrera, M. E. (2017). Aplicación del programa de intervención "talleres de cuidado colaborativo" en familiares de personas con un trastorno alimentario.
264. Hindmarch, I. (1998). The behavioural toxicity of antidepressants. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199807006-00002
265. Hirano, S., Ichikawa, Y., Sato, B., Takefuji, Y., & Satoh, F. (2023). Successful treatment of myalgic encephalomyelitis/chronic fatigue syndrome using hydrogen gas: four case reports. Medical Gas Research. https://doi.org/10.4103/2045-9912.385441
266. Hirose, S. (2003). The Causes of Underdiagnosing Akathisia. Schizophrenia Bulletin. https://doi.org/10.1093/oxfordjournals.schbul.a007027
267. Ho, M.-K., & Siu, A. Y.-C. (2010). High Altitude Medicine.
268. Hoban, T. F. (2001). Sleep-related rhythmic movement disorder. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511711947.030
269. Hollander, E., & Aronowitz, B. (1999). Comorbid social anxiety and body dysmorphic disorder: managing the complicated patient.. PubMed.
270. Hollon, S. D., Stewart, M. O., & Strunk, D. R. (2005). Enduring Effects for Cognitive Behavior Therapy in the Treatment of Depression and Anxiety. Annual Review of Psychology. https://doi.org/10.1146/annurev.psych.57.102904.190044
271. Holovanova, A., Kyrychek, L., Yermolenko, T., & Hladkykh, F. (2017). Pharmacotherapeutic Effect of Stress Protectors in the Age Aspect. Path of Science. https://doi.org/10.22178/pos.29-6
272. Hoon, D. (2012). Traumatic Experiences Disrupt Amygdala – Prefrontal Connectivity. InTech eBooks. https://doi.org/10.5772/48691
273. Hoque, R., & Chesson, A. L. (2010). Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis.. PubMed.
274. Horowitz, M., & Taylor, D. (2022). Distinguishing relapse from antidepressant withdrawal: clinical practice and antidepressant discontinuation studies. BJPsych Advances. https://doi.org/10.1192/bja.2021.62
275. Hossmann, K. (1998). Experimental models for the investigation of brain ischemia. Cardiovascular Research. https://doi.org/10.1016/s0008-6363(98)00075-3
276. Hosztafi, S. (2011). [Heroin addiction].. PubMed.
277. Houdenhove, B. V., Pae, C., & Luyten, P. (2010). Chronic fatigue syndrome: is there a role for non-antidepressant pharmacotherapy?. Expert Opinion on Pharmacotherapy. https://doi.org/10.1517/14656560903487744
278. Housley, S. B., Patel, D., Nyabuto, E., & Reynolds, R. M. (2021). Spinal cord detethering without laminectomy or laminotomy. Surgical Neurology International. https://doi.org/10.25259/sni_942_2021
279. Hughes, J. R. (1999). Comorbidity and smoking. Nicotine & Tobacco Research. https://doi.org/10.1080/14622299050011981
280. Hussain, E., Momin, A., Islam, M., Haque, S., Hossain, M. A., Chowdhury, R., & Hoque, A. (2016). Lafora Body Disease: A Rare Type of Progressive Myoclonic Epilepsy. American Journal of Medical Case Reports. https://doi.org/10.12691/ajmcr-4-3-2
281. Hybels, C. F., Blazer, D. G., & Steffens, D. C. (2006). Partial remission. A common outcome in older adults treated for major depression.. PubMed.
282. Häfner, H. (2002). Prodrome, onset and early course of schizophrenia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544118.011
283. Ignatova, E. S., Bogaevskaya, O. U., & Yumashev, A. V. (2021). Psychodiagnostics as a mandatory element of patient protocols in dentistry. Journal of International Society of Preventive and Community Dentistry. https://doi.org/10.4103/jispcd.jispcd_60_21
284. Indrio, F., Dargenio, V. N., Francavilla, R., Szajewska, H., & Vandenplas, Y. (2023). Infantile Colic and Long-Term Outcomes in Childhood: A Narrative Synthesis of the Evidence. Nutrients. https://doi.org/10.3390/nu15030615
285. Inmaculada, M., & Pérez, P. B. (2016). Neuronal and behavioural effects of social isolation in old age.
286. Is, B., Golovoda, A., Pneumaticos, S. G., & Vlamis, J. (2021). The effect of depression in hospitalization and rehabilitation of patients with spinal cord injury. Acta Orthopaedica Et Traumatologica Hellenica.
287. Ishikawa, S. S., & Raine, A. (2003). Complications obstÈtriques et agressivitÈ.
288. Ismail, K., Crome, I., & O’Brien, P. (2006). The menarche. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139696913.004
289. Itani, R., Soubra, L., Karout, S., Rahme, D., Karout, L., & Khojah, H. M. J. (2022). Primary Dysmenorrhea: Pathophysiology, Diagnosis, and Treatment Updates. Korean Journal of Family Medicine. https://doi.org/10.4082/kjfm.21.0103
290. Ivlieva, N. Y. (2011). [Neurobiology of addictive behavior].. PubMed.
291. Jablensky, A. (2012). Course and outcome of schizophrenia and their prediction. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0078
292. Jaffe, J. H. (1989). Addictions: what does biology have to tell?. International Review of Psychiatry. https://doi.org/10.3109/09540268909110383
293. Jalnapurkar, I., Rafika, N., Tassone, F., & Hagerman, R. J. (2014). Immune mediated disorders in women with a fragile X expansion and FXTAS. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.36748
294. Jameson, D. (2023). Persistent burnout theory of ME/CFS. https://doi.org/10.31234/osf.io/9tjer
295. Janicak, P. G. (2014). Pharmacological Treatment of Psychosis. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg11
296. Jen, J. C. (2015). Familial Hemiplegic Migraine.
297. Jl, M., Llau, M. E., Rascol, O., & Sénard, J. (1994). Drug‐induced parkinsonism: a review. Fundamental and Clinical Pharmacology. https://doi.org/10.1111/j.1472-8206.1994.tb00808.x
298. Jp, L., & Mahieu, E. (1994). [What should be the duration of a treatment with antidepressive agents?].. PubMed.
299. Kahn, D., & Chaplan, R. (2002). The “Good Enough” Mood Stabilizer: A Review of the Clinical Evidence. CNS Spectrums. https://doi.org/10.1017/s1092852900017594
300. Kalivas, P. W. (2003). Development and Expression of Behavioral Sensitization. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-343-9_9
301. Kalivas, P. W., Toda, S., Bowers, M. S., Baker, D. L., & Ghasemzadeh, M. B. (2003). The Temporal Sequence of Changes in Gene Expression by Drugs of Abuse. Humana Press eBooks. https://doi.org/10.1385/1-59259-358-5:03
302. Kalsi, S. S., Wood, D. M., & Dargan, P. I. (2011). The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerging Health Threats Journal. https://doi.org/10.3402/ehtj.v4i0.7107
303. Kane, J. M., & Mayerhoff, D. (1989). Do Negative Symptoms Respond to Pharmacological Treatment?. The British Journal of Psychiatry. https://doi.org/10.1192/s0007125000291630
304. Kapoor, D., Singla, D., Singh, J., & Jindal, R. (2013). Paroxysmal autonomic instability with dystonia (PAID) syndrome following cardiac arrest. Singapore Medical Journal. https://doi.org/10.11622/smedj.2013264
305. Kasahara, S., Kato, Y., Takahashi, M., Matsudaira, K., Sato, N., Niwa, S., Momose, T., & Uchida, K. (2023). Case report: Remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole. Frontiers in Pain Research. https://doi.org/10.3389/fpain.2023.1159134
306. Kasatkin, D. S. (2006). [Possible mechanisms of chronic fatigue syndrome in multiple sclerosis].. PubMed.
307. Kayser, B., & Gremion, G. (2004). Chronic fatigue and loss of performance in endurance athletes: overtraining. Schweizerische Zeitschrift für Sportmedizin und Sporttraumatologie.
308. Keller, M. B., & Berndt, E. R. (2002). Depression treatment: a lifelong commitment?. PubMed.
309. Kelly, S. D. (2021). The Acute Stress Syndrome Stabilization Remote Individual (ASSYST-RI) for TeleMental Health Counseling After Adverse Experiences. Psychology and Behavioral Science International Journal. https://doi.org/10.19080/pbsij.2021.16.555932
310. Kemp, S. F., & Lockey, R. F. (2010). Pathophysiology and Organ Damage in Anaphylaxis. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-951-2_3
311. Khaikin, Y., & Mercimek‐Andrews, S. (2016). STXBP1 Encephalopathy with Epilepsy.
312. Khalil, R. B. (2017). Are Hypomanic/Manic Episodes “Induced by” or “Associated with” Quetiapine Initiation?. Drug Safety - Case Reports. https://doi.org/10.1007/s40800-017-0063-y
313. Khan, A. Y., Kalia, R., Ide, G. D., & Ghavami, M. (2017). What Are Realistic Treatment Goals? Lingering Symptoms Require You to Evaluate Pharmacotherapy and Offer Psychosocial Interventions. Current psychiatry.
314. Kieviet, N., Dolman, K. M., Wennink, H. J., Heres, M., & Honig, A. (2012). [Withdrawal in newborns after exposure to psychotropic medications during pregnancy].. PubMed.
315. Kim, S. M. (2000). The Strategy of Clinical Procedure for Determining Brain Death. Korean Journal of Medical Ethics. https://doi.org/10.35301/ksme.2000.3.1.1
316. Kintz, P., Villain, M., & Cirimele, V. (2008). Chemical Abuse in the Elderly: Evidence From Hair Analysis. Therapeutic Drug Monitoring. https://doi.org/10.1097/ftd.0b013e31816bac44
317. Kintz, P., Villain, M., Cirimele, V., Goullé, J., & Ludes, B. (2002). [Crime under the influence of psychoactive drugs: the problem of the duration of detection].. PubMed.
318. Kirkova, J., Walsh, D., Aktaş, A., & Davis, M. P. (2010). Cancer Symptom Clusters: Old Concept But New Data. American Journal of Hospice and Palliative Medicine®. https://doi.org/10.1177/1049909110364048
319. Kirshbaum, M. (2011). Pharmacologic Treatments for Fatigue Associated With Palliative Care. Clinical journal of oncology nursing. https://doi.org/10.1188/11.cjon.438-439
320. Klassen-Bolding, S., & Lenz, A. S. (2016). Post-traumatic Stress Disorder in Youth. https://doi.org/10.63134/mwtw7144
321. Klimek, A. (2010). Physiological Background of Muscular Pain During Skiing and Delayed Muscle Soreness after Skiing. Journal of Human Kinetics. https://doi.org/10.2478/v10078-010-0007-4
322. Knaap, M. S. V. D., Depienne, C., Sedel, F., & Abbink, T. E. M. (2015). CLCN2-Related Leukoencephalopathy.
323. Ko, J. Y., Wolicki, S. B., Barfield, W. D., Patrick, S. W., Broussard, C. S., Yonkers, K. A., Naimon, R., & Iskander, J. (2017). CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome. MMWR Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm6609a2
324. Kobayashi, M., Randrup, A., & Sørensen, G. (1988). Stereotyped behaviour in animals induced by stimulant drugs or by a restricted cage environment: relation to disintegrated behaviour, brain dopamine and psychiatric disease.. PubMed.
325. Konez, O., Pascual-Castroviejo, I., Rocco, C. D., & Ruggieri, M. (2008). Sturge-Weber Syndrome. https://doi.org/10.1007/978-3-211-69500-5_10
326. Kontos, A. P., & McAllister-Deitrick, J. (2017). Concussion in Sport. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.175
327. Koob, G. F., & Zorrilla, E. P. (2010). Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor.. PubMed.
328. Koob, G. F., Kandel, D. B., & Volkow, N. D. (2008). Pathophysiology of Addiction. Psychiatry. https://doi.org/10.1002/9780470515167.ch22
329. Kora, K., & Kaplan, P. (2008). [Hypomania/mania induced by cessation of antidepressant drugs].. PubMed.
330. Kotade, K. B., Pandit, B. S., Gaware, V. M., Dolas, R. T., Dhamak, K. B., Somwanshi, S. B., Nikam, V. K., & Khadse, A. N. (2011). KNOWING DEPRESSION AND PHARMACOLOGICAL, NON-PHARMACOLOGICAL APPROACHES FOR ITS TREATMENT.
331. Koychev, I., & Ebmeier, K. P. (2016). Anxiety in older adults often goes undiagnosed.. PubMed.
332. Kreek, M. J. (2011). Extreme marginalization: addiction and other mental health disorders, stigma, and imprisonment. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2011.06152.x
333. Kretschmer, E. (1994). El delirio de relación sensitivo (1918).. Revista de la Asociación Española de Neuropsiquiatría..
334. Kumar, S., & Browne, M. O. (2003). What are the effects of drug treatments for panic disorder?. Evidence-Based Mental Health. https://doi.org/10.1136/ebmh.6.2.34
335. Kumari, B., & Singh, R. (2016). The Thematic Analysis of Post Traumatic Growth. Indian Journal of Positive Psychology.
336. Kumari, D., & Kumar, P. (2023). Psychosocial Functioning of Females with Chronic Anxiety Disorder. Journal of Psychosocial Well-being. https://doi.org/10.55242/jpsw.2023.4107
337. Kushon, D., McCown, W., Ditre, C. M., Posa, J., Hines, J., & Williams, L. (2008). Stressful Life Events and Alopecia Areata. Loss Grief & Care. https://doi.org/10.1300/j132v07n03_08
338. Kızılkılıç, E. K., Kılboz, B. B., & Üçler, S. (2023). Syndrome of Transient Headache and Neurological Deficits with Cerebrospinal Fluid Lymphocytosis (HaNDL): A Case Report - Is there an Association with the COVID-19 Vaccine?. Annals of Indian Academy of Neurology. https://doi.org/10.4103/aian.aian_1002_22
339. Langguth, B., Bär, R., Wodarz, N., Wittmann, M., & Laufkötter, R. (2011). Paradoxical Reaction in ADHD. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2011.0541a
340. Lanzaro, M. (2017). A new syndrome? The sport identification addiction and the case of Italian football ultra-fanatical support. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.508
341. Latas, M., Jerotić, S., Tiosavljević, D., & Lačković, M. (2023). Separation Anxiety Disorder: Is There a Justification for a Distinct Diagnostic Category?. Mind Brain and Education. https://doi.org/10.1007/978-3-031-33013-1_7
342. Leiblum, S. R. (2003). Arousal disorders in women: complaints and complexities. The Medical Journal of Australia. https://doi.org/10.5694/j.1326-5377.2003.tb05392.x
343. Lejoyeux, M., Loughlin, M. M., & Adès, J. (2000). Epidemiology of behavioral dependence: literature review and results of original studies. European Psychiatry. https://doi.org/10.1016/s0924-9338(00)00201-7
344. Lemogne, C., Pitron, Jy, R., Limosin, F., & Cathébras, P. (2019). What attitude towards a patient with somatoform disorder?. PubMed.
345. Lepping, P., Huber, M., & Freudenmann, R. W. (2015). How to approach delusional infestation. BMJ. https://doi.org/10.1136/bmj.h1328
346. Lheureux, P., & Penaloza, A. (2004). [Ototoxicity-related dysequilibrium].. PubMed.
347. Lim, S., Wadia, P. M., Armstrong, M. J., Schenck, C. H., & Lang, A. E. (2015). Augmented Restless Legs Syndrome with Marked Hyperkinesias and Impulsive‐Compulsive Behaviors. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.12299
348. Lloyd, A. R. (2013). Fatigue after infection: aetiology and pathophysiology. Microbiology Australia. https://doi.org/10.1071/ma13047
349. Londoño, F. U., Franco, J. G., Franco, L. F. M., & Tobón, L. A. L. (2005). Ejes neuroendocrinos del estrés, síndrome metabólico y alteraciones psiquiátricas del síndrome de Cushing. IATREIA. https://doi.org/10.17533/udea.iatreia.4249
350. Long, A., Mitchell, S., Kashanin, D., Williams, V., Prina‐Mello, A., Shvets, I. V., Kelleher, D., & Volkov, Y. (2004). A Multidisciplinary Approach to the Study of T Cell Migration. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1322.035
351. Lundeberg, T., & Lund, I. (2008). Acupuncture for Preconditioning of Expectancy And/Or Pavlovian Extinction. Acupuncture in Medicine. https://doi.org/10.1136/aim.26.4.234
352. Lyvers, M. (1998). Drug addiction as a physical disease: The role of physical dependence and other chronic drug-induced neurophysiological changes in compulsive drug self-administration.. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037//1064-1297.6.1.107
353. Lyvers, M. (1998). Drug addiction as a physical disease: The role of physical dependence and other chronic drug-induced neurophysiological changes in compulsive drug self-administration.. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/1064-1297.6.1.107
354. López, S. R. (2021). Pathophysiology of Posttraumatic Stress Disorder (PTSD) In Asthma Patients. Journal of Traumatic Stress Disorders & Treatment.
355. López‐Ibor, M. I., López-Ibor, J. J., & Herreros, M. H. (1998). [Landau-Kleffner syndrome (acquired aphasia with epilepsy). Etiopathology and response to treatment with anticonvulsants].. PubMed.
356. Maceira, E., Lesar, T. S., & Smith, H. S. (2012). Medication related nausea and vomiting in palliative medicine.. PubMed. https://doi.org/10.3978/j.issn.2224-5820.2012.07.11
357. Magyar, M., Hajnal, B., Gyüre, T., & Ertsey, C. (2015). Fájdalomcsillapító-túlhasználathoz társuló fejfájás. Orvosi Hetilap. https://doi.org/10.1556/650.2015.30209
358. Mahato, T. K., Ojha, S. K., Singh, V., & Parihar, S. P. S. (2021). Addiction withdrawal syndrome: Needs medications, education, counselling &amp; support. World Journal of Advanced Research and Reviews. https://doi.org/10.30574/wjarr.2021.12.2.0573
359. Mahon, S. M., & Carr, E. (2021). Fatigue/Lack of Endurance: Common Side Effect. Clinical journal of oncology nursing. https://doi.org/10.1188/21.cjon.s2.25
360. Malenfant, M., Tremblay, S., Laurin, D., & Lefèbvre, J. (2008). L'utilisation du citalopram pour traiter l'agitation et les symptômes psychotiques chez les patients souffrant de démence.
361. Mameniškienė, R., Bast, T., Bentes, C., Canevini, M. P., Dimova, P., Granata, T., Høgenhaven, H., Jakubi, B. J., Marusič, P., Melikyan, G., Michelucci, R., Мukhin, К. Y., Oehl, B., Ragona, F., Rossetti, A. O., Rubboli, G., Schubert‐Bast, S., Stephani, U., Strobel, J., ... Wolf, P. (2011). Clinical course and variability of non-Rasmussen, nonstroke motor and sensory epilepsia partialis continua: A European survey and analysis of 65 cases. Epilepsia. https://doi.org/10.1111/j.1528-1167.2010.02974.x
362. Mandyam, M. C., & Ahuja, N. (2017). Ketamine-Induced Mania During Treatment for Complex Regional Pain Syndrome. Pain Medicine. https://doi.org/10.1093/pm/pnx061
363. Manica, A., Leães, C. G. S., Frey, B. N., & Juruena, M. F. (1999). The role of depression in coronary artery disease. Arquivos Brasileiros de Cardiologia. https://doi.org/10.1590/s0066-782x1999000800012
364. Mantere, O., & Vuorilehto, M. (2015). [Recognition of mood disorders].. PubMed.
365. Marchesi, C., Tonna, M., & Maggini, C. (2008). Obsessive-compulsive disorder followed by psychotic episode in long-term ecstasy misuse. The World Journal of Biological Psychiatry. https://doi.org/10.1080/15622970701459828
366. Mardaga, S., Bassir, M. A., Bracke, J., Dutilleux, A., & Born, J. D. (2017). [Which psychiatric symptoms must raise suspicion about a possible brain tumor ?]. PubMed.
367. Maremmani, I., Pacini, M., Lamanna, F., Pani, P., Perugi, G., Deltito, J., Salloum, I. M., & Akiskal, H. S. (2010). Mood Stabilizers in the Treatment of Substance Use Disorders. CNS Spectrums. https://doi.org/10.1017/s1092852900027346
368. Maricq, A., Jacques, D., Zdanowicz, N., Marchand, É., Evrard, P., Bulpa, P., & Reynaert, C. (2011). Duloxetine-related panic attacks.. Psychiatria Danubina.
369. Markland, A. D., Busby‐Whitehead, J., & Whitehead, W. E. (2022). Fecal Incontinence. Cambridge University Press eBooks. https://doi.org/10.1017/9781108942751.029
370. Martins, S. F., Quarenta, J., Teixeira, T., & Ribeiro, J. (2021). Cocaine bugs: A brief case report of cocaine-induced delusion of parasitosis. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.1708
371. Martínez-Aguayo, J. C., Middleton, F., Nahuelcura, K., Arancibia, M., Meza-Concha, N., Sepúlveda, E., Gepp, A., Escobar, R., & Madrid, E. (2017). Caracterización fenomenológica de las conductas repetitivas impulsivas orientadas hacia el cuerpo y el trastorno por excoriación en estudiantes universitarios. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272017000400221
372. Martı́n, M. A., Lucía, A., Arenas, J., & Andreu, A. L. (2014). Glycogen Storage Disease Type V.
373. Matsumoto, R., Sakamoto, M., & Ikeda, A. (2017). [Autoimmune and Epilepsy].. PubMed. https://doi.org/10.11477/mf.1416200879
374. Mauri, M., & Ramacciotti, D. (2006). Sintomi Psichici e Somatici dei Disturbi dell'Umore: razionali di terapia. Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology.
375. Mavrogiorgou, P., Juckel, G., & Bauer, M. (2001). Rezidivierende paranoid-halluzinatorische Psychose nach Beginn einer Hungerkur bei einer Patientin mit Anorexia nervosa. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-2001-13932
376. Mayberg, H. S., & Lozano, A. M. (2002). Penfield revisited?. Neurology. https://doi.org/10.1212/wnl.59.9.1298
377. McFadden, K. M. (2010). Cross-Addiction: From Morbid Obesity to Substance Abuse. Bariatric Nursing and Surgical Patient Care. https://doi.org/10.1089/bar.2010.9922
378. McGorry, P. D., Purcell, R., Goldstone, S., & Amminger, G. P. (2011). Age of onset and timing of treatment for mental and substance use disorders: implications for preventive intervention strategies and models of care. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0b013e3283477a09
379. McGowan, J. C., Shkolnikov, Y. P., Sala, J. B., & Ray, R. M. (2008). Diffuse electrical injury: Questioning the scientific basis. Conference proceedings - Canadian Conference on Electrical and Computer Engineering. https://doi.org/10.1109/ccece.2008.4564890
380. McPherson, M. L., Davis, M. P., Bruera, É., & Fabbro, E. D. (2012). A Critical Review of Evidence-Based Non-Pain Symptom Management at End of Life (P14). Journal of Pain and Symptom Management. https://doi.org/10.1016/j.jpainsymman.2011.12.016
381. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly].. PubMed.
382. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). Diagnóstico y tratamiento del insomnio en el adulto mayor.
383. Mehić, B. (2012). Molecular and Genetic Basis of Stress. Bosnian Journal of Basic Medical Sciences. https://doi.org/10.17305/bjbms.2012.2496
384. Meinck, H., & Thompson, P. D. (2002). Stiff man syndrome and related conditions. Movement Disorders. https://doi.org/10.1002/mds.10279
385. Melo-Dias, C., Apóstolo, J., & Cardoso, D. (2014). Effectiveness of progressive muscle relaxation training for adults diagnosed with schizophrenia: a systematic review protocol. The JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/jbisrir-2014-1639
386. Meléndez, R. I., & Kalivas, P. W. (2008). The Basic Science of Addiction. https://doi.org/10.1093/oso/9780195300550.003.0006
387. Mendez, M. F. (2017). What is the Relationship of Traumatic Brain Injury to Dementia?. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-161002
388. Menzel, J. E., & Thompson, J. K. (2010). Food Addiction. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0365
389. Meyer, J. S., & Hamel, A. F. (2014). Models of Stress in Nonhuman Primates and Their Relevance for Human Psychopathology and Endocrine Dysfunction. ILAR Journal. https://doi.org/10.1093/ilar/ilu023
390. Meza, E. G. L., Téllez, F. C., Guevara, I. M. A., González-Aragón, M. D. C. F., & Calderón, L. Á. R. (2003). Estado epiléptico no convulsivo asociado a enfermedad de Lafora: presentación de dos casos. Revista de Neurología. https://doi.org/10.33588/rn.3710.2003290
391. Midorikawa, A., & Kawamura, M. (2008). [Different stages of human memory consolidation system deficits revealed by patients with epileptic amnesia].. Brain and nerve.
392. Miettinen, O. S., & Flegel, K. M. (2003). Elementary concepts of medicine: VII. Course of illness: manifestations, complications, outcome. Journal of Evaluation in Clinical Practice. https://doi.org/10.1046/j.1365-2753.2003.00420.x
393. Miller, K. C., Stone, M. S., Huxel, K. C., & Edwards, J. E. (2010). Exercise-Associated Muscle Cramps. Sports Health A Multidisciplinary Approach. https://doi.org/10.1177/1941738109357299
394. Miller, M. W., Marx, B. P., & Keane, T. M. (2010). Posttraumatic Stress Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0699
395. Mitchell, P. B., Goodwin, G. M., Johnson, G. F., & Hirschfeld, R. M. A. (2008). Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disorders. https://doi.org/10.1111/j.1399-5618.2007.00559.x
396. Mitropoulos, G. B. (2021). Being psychotic is not necessarily being ill: Psychotic continuum and the relevance of lacanian psychoanalytic approach. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.2127
397. Miyamoto, T., & Miyamoto, M. (2011). Combinations of Markers Provide Clues to the Underlying Neurodegenerative Disorder in REM Sleep Behavior Disorder. InTech eBooks. https://doi.org/10.5772/18923
398. Miyata, H., Kono, J., & Yanagita, T. (2005). Clinical features of nicotine dependence.
399. Montalto, S. A. (2021). Intrapartum Asphyxia and Its Sequelae. Cambridge University Press eBooks. https://doi.org/10.1017/9781108863049.061
400. Montejo, Á. L., Montejo, L., & Navarro-Cremades, F. (2015). Sexual side-effects of antidepressant and antipsychotic drugs. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0000000000000198
401. Moreau, J., Scherschlicht, R., Jenck, F., & Martin, J. R. (1995). Chronic mild stress-induced anhedonia model of depression. Behavioural Pharmacology. https://doi.org/10.1097/00008877-199511000-00003
402. Morin, C. (2009). [Sense of personal identity and focal brain lesions].. PubMed. https://doi.org/10.1684/pnv.2009.0156
403. Morrigan, C. (2017). Failure to Comply: Madness and/as Testimony. Canadian Journal of Disability Studies. https://doi.org/10.15353/cjds.v6i3.366
404. Morrison, M. C. T. (2003). WHIPLASH – WHY THE ARGUMENTS?. Orthopaedic Proceedings.
405. Morylowska-Topolska, J., Ziemiński, R., Molas, A., Gajewski, J., Flis, M., Stelmach, E., & Karakuła‐Juchnowicz, H. (2016). Schizophrenia and anorexia nervosa – reciprocal relationships. A literature review. Psychiatria Polska. https://doi.org/10.12740/pp/onlinefirst/63514
406. Motevalli, H., Hosseinzadeh, R., Barary, M., Sio, T. T., & Manouchehri, A. (2022). Acute poisoning due to massive leaking of methamphetamine in a methamphetamine body packer: A case report. Authorea (Authorea). https://doi.org/10.22541/au.164761079.96603410/v1
407. Mountain, B. W. (2008). The Efficacy of Oral Dexmedetomidine as an Anesthetic Pre-operative Medication and as a Deterrent to Emergence Delirium.
408. Mundy, R. R., Moore, S. C., Corey, J. B., & Mundy, G. D. (1994). Disability Syndrome. Workplace Health & Safety. https://doi.org/10.1177/216507999404200806
409. Munir, S., & Takov, V. (2021). Generalized Anxiety Disorder. StatPearls.
410. Musálek, M. (2011). Pathologisches Spielen: Impulskontrollstörung oder Sucht?. Suchttherapie. https://doi.org/10.1055/s-0031-1284655
411. Méndez, A. V., Silva, P. L. N. D., Gonçalves, L. G. V., Chaves, S. C. D. S., Veiga, R. M., Mendez, A. E. R., Camilo, M. V. L., Mattos, L. C. D. A. N., Filho, M. R. S., Silva, R. D. G. D., Lima, G. F., Ferreira, C. S., & Santos, L. G. D. S. (2023). NEURONAL DAMAGE IN STATE EPILEPTICUS - LITERATURE REVIEW. International Journal of Health Science. https://doi.org/10.22533/at.ed.1593752318094
412. Möller, H., Demyttenaere, K., Sacchetti, E., Rush, A. J., & Montgomery, S. (2003). Improving the chance of recovery from the short- and long-term consequences of depression. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-200307000-00004
413. Mărgescu, M., Mărgescu, C., Pantis, R. E., Chiriac, M.-I., & Cornean, R. (2016). Neuropsychiatric Manifestations of Celiac Disease in Young Child – Case Report. International Journal of Celiac Disease. https://doi.org/10.12691/ijcd-3-2-4
414. Nakata, C., Nara, K., Kinoshita, F., Kikuchi, K., & Asai, M. (2015). [Alcohol withdrawal syndrome showing various progress: A case report].. PubMed.
415. Nakken, K. O., & Johannessen, S. I. (2008). [Seizure exacerbation caused by antiepileptic drugs].. PubMed.
416. Negueruela-López, M., Mardomingo, M. J., & Sánchez, P. G.-P. (2012). Prodromal obsessive-compulsive symptoms in a case of schizophrenia.. PubMed.
417. Newman, L. C. (2008). Classification and Diagnosis of Secondary Headaches: Substances, Metabolic Disorders, EENT Causes, and Neuralgias. https://doi.org/10.1093/oso/9780195366730.003.0009
418. Niebles, C., & Díaz, J. A. A. (2011). Y después del estatus convulsivo.
419. Nielsen, J. F., Klemar, B., Hansen, H., & Sinkjær, T. (1995). A new treatment of spasticity with repetitive magnetic stimulation in multiple sclerosis.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.58.2.254-a
420. Nitkowski, D., & Petermann, F. (2010). Selbstverletzendes Verhalten und komorbide psychische Störungen: ein Überblick. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-0029-1245772
421. Noble, F., & Roques, B. P. (2003). Inhibitors of Enkephalin Catabolism. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-343-9_5
422. Noel, N., Seibell, P., Nadeau, J., & Storch, E. (2016). Treating just-right symptoms in geriatric obsessive-compulsive disorder. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.196700
423. Nosek, M. A., & Howland, C. A. (1998). Abuse and Women with Disabilities.
424. Noël, X., Bechara, A., Brevers, D., Verbanck, P., & Campanella, S. (2010). Alcoholism and the Loss of Willpower. Journal of Psychophysiology. https://doi.org/10.1027/0269-8803/a000037
425. Nudo, R. J., Barbay, S., & Kleim, J. A. (2000). Role of Neuroplosticity in Functional Recovery After Stroke. https://doi.org/10.1093/oso/9780195120264.003.0009
426. Nugraha, S. (2021). Postoperative Complication and Depression: A Literature Review. Open Access Indonesian Journal of Medical Reviews. https://doi.org/10.37275/oaijmr.v1i2.36
427. Nugraha, S. (2021). Postoperative Complication and Depression: A Literature Review. Open Access Indonesian Journal of Medical Reviews. https://doi.org/10.37275/oaijmr.v1i2.555
428. Nutt, D., & Nestor, L. J. (2018). Key elements of addiction. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198797746.003.0003
429. Okuniewska, A., Walczuk, B. I., Czubek, M., & Biernat, W. (2011). Recurrent Deep Ulcers Resembling Rare Cancers as a Form of Factitious Disorder. Acta Dermato Venereologica. https://doi.org/10.2340/00015555-1027
430. Olagunju, A. E., & Ghoddusi, F. (1994). Attention deficit hyperactivity disorder in adults. American Journal of Psychiatry. https://doi.org/10.1176/ajp.151.5.633
431. Ortiz, S. R., Carrillo-Albornoz, E. J. O., & Coque, J. A. R. (2016). La intervención policial con sujetos confuso-agitados: El denominado “delirio agitado”. Cuadernos de la Guardia Civil: Revista de seguridad pública.
432. Os, J. V., Praag, H. M. V., & Kloet, E. R. D. (2004). Stress, the brain and depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544422.010
433. Osborn, C. J., & Iarussi, M. M. (2017). Addictions Counseling. Routledge eBooks. https://doi.org/10.4324/9781315537061-13
434. Osterman, J. E., Erdos, B. Z., Oldham, M., & Ivkovic, A. (2010). Antidepressant Treatments in PTSD. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-435-7_7
435. Otsuka, K., Kato, S., Abe, T., SUGIYAMA, H., Watanabe, Y., Kobayashi, T., & Okajima, Y. (2002). [Classification of long-term clinical course of 'atypical psychosis': a 20-year follow-up study at a medical school hospital].. PubMed.
436. Ouvrier, R., & Billson, F. A. (1988). Benign Paroxysmal Tonic Upgaze of Childhood. Journal of Child Neurology. https://doi.org/10.1177/088307388800300305
437. Palmer, E. G., Sornalingam, S., Page, L., & Cooper, M. (2023). Withdrawing from SSRI antidepressants: advice for primary care. British Journal of General Practice. https://doi.org/10.3399/bjgp23x732273
438. Paradela, E. M. P. (2011). Depressão em idosos. Revista Hospital Universitário Pedro Ernesto (TÍTULO NÃO-CORRENTE). https://doi.org/10.12957/rhupe.2011.8850
439. Parano, E., Pappalardo, X. G., Pavone, P., Ruggieri, M., & Cavallaro, S. (2016). Child Abuse Syndrome (CAS): A Newly Recognized Distinct Entity. The Open Neurology Journal. https://doi.org/10.2174/1874205x01610010030
440. Paredes, D. F. D., Farfán, J. C. P., Orellana, J. M. F., & Legarda, A. A. B. (2019). Trastorno disfórico premenstrual. RECIAMUC. https://doi.org/10.26820/reciamuc/3.(1).enero.2019.199-217
441. Pary, R., Lippmann, S., & Tobias, C. R. (1988). Depression and Alcoholism: Clinical Considerations in Management. Southern Medical Journal. https://doi.org/10.1097/00007611-198812000-00016
442. Passantino, A., & Masucci, M. (2016). Congenital and inherited neurologic diseases in dogs and cats: Legislation and its effect on purchase in Italy. Veterinary World. https://doi.org/10.14202/vetworld.2016.437-443
443. Patel, A., Moreland, T., Haq, F., Siddiqui, F., Mikul, M., Qadir, H., & Raza, S. (2011). Persistent Psychosis After a Single Ingestion of “Ecstasy” (MDMA). The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.11l01200
444. Paulin, L. F. R. D. S., Reis, E. F. D., & Rodrigues, E. P. (2008). Síndrome de descontinuação dos antidepressivos.
445. Peeters, F., & Zandbergen, J. (1999). [Severe withdrawal symptoms with fever during paroxetine tapering off].. PubMed.
446. Peitl, M. V., Prološčić, J., Zelić, S. B., Skarpa-Usmiani, I., & Peitl, V. (2011). Symptoms of agitated depression and/or akathisia.. PubMed.
447. Peng, K., & Rozen, T. D. (2023). Update in the understanding of new daily persistent headache. Cephalalgia. https://doi.org/10.1177/03331024221146314
448. Penza, K. M., Heim, C., & Nemeroff, C. B. (2006). Trauma and Depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511841262.017
449. Perrin, R., Edwards, J., & Hartley, P. (1998). An evaluation of the effectiveness of osteopathic treatment on symptoms associated with Myalgic Encephalomyelitis. A preliminary report. Journal of Medical Engineering & Technology. https://doi.org/10.3109/03091909809009993
450. Perucca, E., Gram, L. F., Avanzini, G., & Dulac, O. (1998). Antiepileptic Drugs as a Cause of Worsening Seizures. Epilepsia. https://doi.org/10.1111/j.1528-1157.1998.tb01268.x
451. Petit, J., & Sansone, R. A. (2011). A Case of Interdose Discontinuation Symptoms With Venlafaxine Extended Release. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.11l01140
452. Petrenko, A. B., Takamatsu, M., & Baba, H. (2012). Should We Use Psychostimulant Drugs to Boost the Emergence from General Anesthesia?. Anesthesiology. https://doi.org/10.1097/aln.0b013e318272d898
453. Phillips, K. A. (2014). Body Dysmorphic Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg22
454. Phillips, K. A. (2014). Body Dysmorphic Disorder: Common, Severe and in Need of Treatment Research. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000366035
455. Pichler, W. J., & Pichler, C. E. (2009). DRESS (Drug Rash with Eosinophilia and Systemic Symptoms). Allergologie. https://doi.org/10.5414/alp32365
456. Pignalberi, C., Ricci, R. P., & Santini, M. (2002). [Psychological stress and sudden death].. PubMed.
457. Pina, I. B., Gorostiza, P. R., Yllán, P. V., & Fernández, J. V. (2000). [Persisting and late onset psychotic disorder due to consumption of ecstasy (MDMA)].. PubMed.
458. Pollanen, M. S. (2017). The pathology of torture. Forensic Science International. https://doi.org/10.1016/j.forsciint.2017.12.022
459. Pomerantz, J. M. (2008). Early Antidepressant Treatment Is Effective for Post-Stroke Depression.
460. Pontius, A. A. (1988). Limbic System-Frontal Lobes' Role in Subtypes of “Atypical Rape”. Psychological Reports. https://doi.org/10.2466/pr0.1988.63.3.879
461. Porcelli, P., Laera, D., Mastrangelo, D., & Masi, A. D. (2012). Prevalence of Allostatic Overload Syndrome in Patients with Chronic Cardiovascular Disease. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000341179
462. Pounder, D. J., Karch, S. B., & Stephens, B. G. (1998). Acute excited states and sudden death. BMJ. https://doi.org/10.1136/bmj.316.7138.1171
463. Prasad, K., Prasad, M., Ramaratnam, S., & Marson, A. G. (2015). Status epilepticus. https://doi.org/10.1002/9781119067344.ch9
464. Pujol, R., & Puel, J. (1999). Excitotoxicity, Synaptic Repair, and Functional Recovery in the Mammalian Cochlea: A Review of Recent Findings. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1999.tb08646.x
465. Pyszora, N., Fahy, T., & Kopelman, M. D. (2014). Amnesia for violent offenses: factors underlying memory loss and recovery.. PubMed.
466. Pérez, E. J. P., García, C. P., Mota, G. R., León, J. M. R. S. D., Luque, M. L., & Arroyo, Á. O. (2009). Déficit de atención e hiperactividad en adultos con adicción a sustancias: ¿TDAH o síndrome secundario al abuso de sustancias?.
467. Păunica, S., Giurgiu, M., Vasilache, A., Păunică, I., Motofei, I. G., Vasilache, A., Dumitriu, H., & Dumitriu, A. S. (2016). Finasteride adverse effects and post-finasteride syndrome; implications for dentists. Journal of Mind and Medical Sciences. https://doi.org/10.22543/2392-7674.1039
468. Płytycz, B., & Seljelid, R. (2002). Stress and immunity: minireview.. PubMed.
469. Rabe‐Jabłońska, J. (1998). [Results of long-term observation (3-11 years) of patients with dual diagnosis: body dysmorphic disorder and delusional disorder, somatic type].. PubMed.
470. Racciatti, D., Barberio, A., Vecchiet, J., & Pizzigallo, E. (1999). Clinical and Pathogenetical Characterization of 238 Patients of a Chronic Fatigue Syndrome Italian Center. Journal of Chronic Fatigue Syndrome. https://doi.org/10.1300/j092v05n03_05
471. Raff, H., & Zhang, C. D. (2023). A New Approach — Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency. NEJM Evidence. https://doi.org/10.1056/evide2200306
472. Raj, S., & Gale, S. A. (2017). [P4–173]: NEW ONSET PSYCHOTIC SYMPTOMS AS THE INITIAL PRESENTATION OF EARLY ONSET ALZHEIMER'S DISEASE. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2017.06.2040
473. Ranganathan, A., & Beitman, B. D. (1998). Panic disorder: a different perspective.. PubMed.
474. Rani, M. K. S., Fathima, S. T., Gayathri, S. L., Pavani, M., & Swathi, Y. (2022). Detection of Autism Spectrum Disorder using Machine Learning. International Journal of Advanced Research in Science Communication and Technology. https://doi.org/10.48175/ijarsct-7600
475. Rao, S. (2016). Prolonged coma after anesthesia. Journal of Anaesthesiology Clinical Pharmacology. https://doi.org/10.4103/0970-9185.173339
476. Rao, T. S., & Kumar, M. A. (2008). Agenda for specialty section in addiction medicine. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.44741
477. Reddy, S., Elsayem, A., & Talukdar, R. (2005). Palliative Care. CRC Press eBooks. https://doi.org/10.1201/b14119-59
478. Ree, J. M. V., Koob, G. F., Higgins, G. A., Naranjo, C. A., & Zvartau, E. (1995). Neurohormonal Systems Underlying Drug Addiction: Relevance for Treatment Strategies. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-7218-8_27
479. Reichenberg, L. W., & Seligman, L. (2016). Obsessive‐Compulsive and Related Disorders. https://doi.org/10.1002/9781394259465.ch7
480. Reilly, T., Atkinson, G., Gregson, W., Drust, B., Forsyth, J., Edwards, B., & Waterhouse, J. (2006). Some chronobiological considerations related to physical exercise.. PubMed.
481. Rengifo, C. A. (2014). Estudio de caso: Trastorno Obsesivo-Compulsivo. Revista de Investigación Universitaria. https://doi.org/10.17162/riu.v3i2.519
482. Renoir, T. (2013). Selective Serotonin Reuptake Inhibitor Antidepressant Treatment Discontinuation Syndrome: A Review of the Clinical Evidence and the Possible Mechanisms Involved. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2013.00045
483. Rigaud, J., Lheureux, P., & Sauder, P. (2006). Prise en charge symptomatique : neurologique, respiratoire, hémodynamique et hépatique des intoxications graves par médicaments et substances illicites. Réanimation. https://doi.org/10.1016/j.reaurg.2006.08.002
484. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2012.0227
485. Romero‐Sandoval, E. A. (2011). Depression and Pain. Anesthesiology. https://doi.org/10.1097/aln.0b013e31822ec185
486. Rosa, E. F., & Rustiaty, N. (2018). Affective Disorders in The Elderly: The Risk of Sleep Disorders. International Journal of Public Health Science (IJPHS). https://doi.org/10.11591/ijphs.v7i1.9960
487. Rosen, R. C., Lane, R., & Menza, M. (1999). Effects of SSRIs on Sexual Function. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199902000-00013
488. Routledge, P. A. (2003). Adverse Drug Reactions and Interactions: Mechanisms, Risk Factors, Detection, Management and Prevention. https://doi.org/10.1002/0470014199.ch2
489. Rowe, P. C., Underhill, R., Friedman, K. J., Gurwitt, A., Medow, M. S., Schwartz, M., Speight, N., Stewart, J. M., Vallings, R., & Rowe, K. S. (2017). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer. Frontiers in Pediatrics. https://doi.org/10.3389/fped.2017.00121
490. Rowland, D. L., & Incrocci, L. (2008). Appendix: Alphabetical Listing of DSM‐IV Sexual and Gender Identity Disorders Reviewed. https://doi.org/10.1002/9781118269978.app1
491. Roy, P. K. (2023). Ameliorating Obsessive-Compulsive and Related Disorder with Oppositional Defiant Disorder and Enuresis Through Behaviour Therapy Approach – A Case Study. Psychology and Mental Health Care. https://doi.org/10.31579/2637-8892/218
492. Rubin, J. N. (2018). CONSISTENT PATTERNS IN SECONDARY HEALTH EFFECTS OF DISASTERS. Abstracts with programs - Geological Society of America. https://doi.org/10.1130/abs/2018am-319679
493. Rucci, J. M., & Feinstein, R. E. (2014). Neurocognitive Disorders and Mental Disorders Due to Another Medical Condition. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199326075.003.0005
494. Ruiz‐Rizzo, A. L., & Restrepo, F. L. (2008). Memoria explícita en el trastorno depresivo mayor. IATREIA. https://doi.org/10.17533/udea.iatreia.4479
495. Rus-Makovec, M. (2012). Craving and Indicators of Depression and Anxiety Levels in Different Time Points of Intensive Alcohol Dependence Treatment. InTech eBooks. https://doi.org/10.5772/29787
496. Röhr, S., Villringer, A., Angermeyer, M., Luck, T., & Riedel‐Heller, S. G. (2017). Outcomes of stable and unstable reports of subjective cognitive decline – results from the Leipzig Longitudinal Study of the Aged (LEILA75+). Das Gesundheitswesen. https://doi.org/10.1055/s-0037-1605826
497. Sabo-Graham, T., & Seay, A. R. (1998). Consultation with the Specialist: Management of Status Epilepticus in Children. Pediatrics in Review. https://doi.org/10.1542/pir.19.9.306
498. Saguil, A. (2005). Evaluation of the patient with muscle weakness.. PubMed.
499. Sahakian, B. J., & Morein‐Zamir, S. (2011). Depression and resilience: insights from cognitive, neuroimaging, and psychopharmacological studies. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199600434.003.0023
500. Salazar, F. (2009). [Psychosocial aspects of childhood epilepsy].. PubMed.
501. Saleh, S. C. (2023). Anesthesia-Related in Recovery Room Complication: Coma and Delayed Emergence. Jurnal Komplikasi Anestesi. https://doi.org/10.22146/jka.v1i1.5532
502. Salim, M. S., & Anjum, Q. (2003). Role of nerve blocks in chronic pain managementi. Rawal Medical Journal.
503. San, L., Herrero, R. M. D., & Martí, B. A. (2004). Aspectos generales de la patología dual.
504. Sansone, R. A., & Sansone, L. A. (2010). Medically Unexplainable Somatic Symptoms: A Coat With Many Psychiatric Colors. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.09l00879gre
505. Sansone, R. A., & Sansone, L. A. (2010). SSRI-Induced Indifference.. PubMed.
506. Santos, A. D. O., Soares, A. L. F., Silva, H. D. T. D., Santos, J. S. D., Silva, L. G. P. D., Silva, W. H. F. D., & Félix, P. T. (2021). Unveiling post-traumatic stress disorder: a literature review. IJS - International Journal of Sciences. https://doi.org/10.29327/229003.2.3-16
507. Sapin, P. M., & Muller, J. E. (1999). Triggers of Acute Coronary Syndromes. Contemporary cardiology. https://doi.org/10.1007/978-1-59259-731-4_3
508. Sapolsky, R. M. (2000). Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.57.10.925
509. Sardesai, A., Muneshwar, K. N., Bhardwaj, M., & Goel, D. B. (2023). The Importance of Early Diagnosis of Somatic Symptom Disorder: A Case Report. Cureus. https://doi.org/10.7759/cureus.44554
510. Sarkar, S., Bhatia, G., & Dhawan, A. (2023). Clinical Practice Guidelines for Assessment and Management of Patients with Substance Intoxication Presenting to the Emergency Department. Indian Journal of Psychiatry. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_490_22
511. Savina, S., Chernicova, I., & Zaydiner, B. (2021). A Review on Depressive Disorders in Cancer Patients. Book Publisher International (a part of SCIENCEDOMAIN International). https://doi.org/10.9734/bpi/idhr/v3/12364d
512. Scheiber-Nogueira, M.-C. (2009). Troubles sexuels et syndrome de la queue-de-cheval Sexual dysfunction in cauda equina syndrome.
513. Schneier, F. R., Bruce, L. C., & Heimberg, R. G. (2014). Social Anxiety Disorder (Social Phobia). American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg18
514. Schott, G. D. (2001). Delayed onset and resolution of pain: Some observations and implications. Brain. https://doi.org/10.1093/brain/124.6.1067
515. Schulman, E. A. (2011). Abuse and Maltreatment: Their Effect on Headache. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2011.02020.x
516. Schwabe, L., Dickinson, A., & Wolf, O. T. (2011). Stress, habits, and drug addiction: A psychoneuroendocrinological perspective.. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/a0022212
517. Schwartzman, R. J., & Vorobeychik, Y. (2006). Chronic Regional Pain Syndrome I/II. https://doi.org/10.1093/oso/9780195170320.003.0024
518. Schweitzer, J. B. (2010). Attention‐Deficit/Hyperactivity Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0096
519. Seo, J., & Jeong, D. U. (2012). Sleep and Pain. Sleep Medicine and Psychophysiology. https://doi.org/10.14401/kasmed.2012.19.2.063
520. Sevarino, K. A., & Shelby, B. C. (2015). Stimulant Use Disorders. Psychiatry. https://doi.org/10.1002/9781118753378.ch80
521. Shah, J. S., Owen-Smith, O., Coley, S. M., & Rangasami, J. (2000). A survey of peripheral nerve stimulator (PNS) use. European Journal of Anaesthesiology. https://doi.org/10.1046/j.1365-2346.2000.00586.x
522. Shah, J. S., Owen-Smith, O., Coley, S. M., & Rangasami, J. (2000). A survey of peripheral nerve stimulator (PNS) use. European Journal of Anaesthesiology. https://doi.org/10.1097/00003643-200004000-00012
523. Shams, J., Rahmani, B., Asefi, F., & Daneshfar, S. (2010). CATATONIA DEVELOPMENT IN A SCHIZOAFFECTIVE PATIENT FOLLOWING ELECTROCONVULSIVE THERAPY: CASE REPORT.
524. Sheets, E. S., & Brosse, A. L. (2010). Major Depressive Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0522
525. Shelton, P. S., & McLendon, A. N. (2011). New Symptoms in Older Adults: Disease or Drug?. Generations.
526. Shields, L. B. E., Rolf, C. M., & Hunsaker, J. C. (2015). Sudden Death Due To Acute Cocaine Toxicity—Excited Delirium in a Body Packer. Journal of Forensic Sciences. https://doi.org/10.1111/1556-4029.12860
527. Shirley, K. L., Norelli, L. J., & Smith, H. S. (2008). “Impulsology” <i>A New Paradigm for Addiction</i>. https://doi.org/10.1093/oso/9780195300550.003.0013
528. Shivani, R., Goldsmith, R. J., & Anthenelli, R. M. (2002). Alcoholism and Psychiatric Disorders: Diagnostic Challenges.. Alcohol Research & Health.
529. Sibarani, M. H. R. (2015). Gangguan Muskuloskeletal pada Diabetes Melitus. Cermin Dunia Kedokteran.
530. Sidhu, H., Venkatanarasimha, N., Bhatnagar, G., Vardhanabhuti, V., Fox, B., & Suresh, S. P. (2012). Imaging Features of Therapeutic Drug–induced Musculoskeletal Abnormalities. Radiographics. https://doi.org/10.1148/rg.321115041
531. Siegel, S. (1988). Drug anticipation and the treatment of dependence.. PubMed.
532. Silver, R. M., & Airoldi, J. (2016). 27. Inherited thrombophilia. CRC Press eBooks. https://doi.org/10.1201/9781315200910-28
533. Singh, N., & Koul, S. (2016). Anxiety Related To Chronic Cervical Spodylosis: A Case Report. International Journal of Indian Psychology. https://doi.org/10.25215/0303.116
534. Sinha, R., & Singh, S. (2021). Clinical and Electroencephalogram Correlation of Self-Limited Epilepsy with Autonomic Seizures. Indian Pediatrics Case Reports. https://doi.org/10.4103/ipcares.ipcares_287_21
535. Skjelstad, D. V., Holte, A., & Malt, U. F. (2012). Putative early manifestations of bipolar II disorder emerge later in the initial prodrome than manifestations hypothesized to be unrelated: an exploratory study. Early Intervention in Psychiatry. https://doi.org/10.1111/j.1751-7893.2012.00348.x
536. Smith, A. D., & Aronson, J. K. (2002). Adverse reactions to drugs. https://doi.org/10.1093/oso/9780192632340.003.0009
537. Smith, B. H., Molina, B. S. G., & Pelham, W. E. (2002). The Clinically Meaningful Link Between Alcohol Use and Attention Deficit Hyperactivity Disorder.. Alcohol Research & Health.
538. Smith, P. J., Attix, D. K., Weldon, B. C., Greene, N. H., & Monk, T. G. (2009). Executive Function and Depression as Independent Risk Factors for Postoperative Delirium. Anesthesiology. https://doi.org/10.1097/aln.0b013e31819b5bc2
539. Sobański, J. A., Müldner-Nieckowski, Ł., Klasa, K., Rutkowski, K., & Dembińska, E. (2012). [Sexual health symptoms and problems in a population of patients in a day hospital for neurotic disorders].. PubMed.
540. Soffer‐Dudek, N. (2023). Obsessive-compulsive symptoms and dissociative experiences: Suggested underlying mechanisms and implications for science and practice. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2023.1132800
541. Sohail, Z., & Macaluso, M. (2015). Fatigue after Depression Responds to Therapy: What Are the Next Steps? A Sufficient Base of Evidence Is Often Lacking to Guide Pharmacotherapy for Fatigue. Current psychiatry.
542. Soler, C. L. (2008). Las reacciones postraumáticas en la infancia y adolescencia maltratada: el trauma complejo. Revista de Psicopatología y Psicología Clínica. https://doi.org/10.5944/rppc.vol.13.num.3.2008.4057
543. Sommer, I. E., & Arango, C. (2017). Moving interventions from after to before diagnosis. World Psychiatry. https://doi.org/10.1002/wps.20454
544. Spanagel, R., Tran, B. X., Reyes‐Gibby, C. C., DeBeck, K., Ibrahim, F., & Bonevski, B. (2016). Advances in Drug Addiction.
545. Spartz, E. J., Freeman, G. M., Brown, K., Farhadian, B., Thienemann, M., & Frankovich, J. (2017). Course of Neuropsychiatric Symptoms After Introduction and Removal of Nonsteroidal Anti-Inflammatory Drugs: A Pediatric Observational Study. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2016.0179
546. Spiller, R. E. (1994). Controversies in Management: Medical treatment works for those with clear diagnosis. BMJ. https://doi.org/10.1136/bmj.309.6969.1646
547. Stegner, A. J., Shields, M. R., Meyer, J. D., & Cook, D. B. (2013). Physical Activity, Stress Reactivity, and Stress-Mediated Pathophysiology. Routledge eBooks. https://doi.org/10.4324/9780203132678-34
548. Steineck, G., Bergmark, K., Henningsohn, L., al‐Abany, M., Dickman, P. W., & Helgason, Á. R. (2002). Symptom Documentation in Cancer Survivors as a Basis for Therapy Modifications. Acta Oncologica. https://doi.org/10.1080/02841860260088782
549. Stephens, J. J., & Byrd, D. L. (2016). Attention-deficit/hyperactivity disorder (ADHD): A review of neuroscientific evidence of developmental delay and dysfunction. Journal of Systems and Integrative Neuroscience. https://doi.org/10.15761/jsin.1000124
550. Stevenson, I. (1969). Single Physical Symptoms as Residues of an Earlier Response to Stress. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-70-6-1231
551. Stewart, J. (2003). Stress and Relapse to Drug Seeking: Studies in Laboratory Animals Shed Light on Mechanisms and Sources of Long‐Term Vulnerability. American Journal on Addictions. https://doi.org/10.1111/j.1521-0391.2003.tb00535.x
552. Stone, J., Carson, A., & Sharpe, M. (2005). Functional symptoms in neurology: management. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2004.061663
553. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
554. Strain, J. J., Klipstein, K., & Newcorn, J. H. (2008). Adjustment Disorders. Psychiatry. https://doi.org/10.1002/9780470515167.ch81
555. Stratyner, H. B. (2006). Multi-factorial Approaches to Substance Use Disorders and Addiction. CNS Spectrums. https://doi.org/10.1017/s109285290001498x
556. Sunitha, P., & Rashmi, P. (2021). Excoriation Disorder (Obsessive-Compulsive Spectrum Disorder). International Journal of Neurological Nursing. https://doi.org/10.37628/ijnn.v7i2.1950
557. Sussman, S., & Ames, S. L. (2008). Concepts of Cessation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511500039.016
558. Swann, I. J., & McCarter, D. H. (1998). Later investigation of head injury.. Emergency Medicine Journal. https://doi.org/10.1136/emj.15.5.344
559. Swartz, C. M. (2002). Olanzapine-Induced Depression. Journal of Pharmacy Technology. https://doi.org/10.1177/875512250201800606
560. Sweet, G., Kim, S., Martin, S. A., Washington, N. B., & Brahm, N. C. (2017). Psychiatric symptoms and synthetic cannabinoid use: Information for clinicians. Mental Health Clinician. https://doi.org/10.9740/mhc.2017.07.156
561. Szkodny, L. E., Jacobson, N. C., Llera, S. J., & Newman, M. G. (2014). Generalized Anxiety Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg19
562. Sáiz, P. A., G-Portilla, M., Paredes, M., Bascarán, T., & Bobes, J. (2002). Instrumentos de evaluación en alcoholismo. Adicciones. https://doi.org/10.20882/adicciones.534
563. Sánchez, L. C., Cardona, A., cordoba, S., Silva, A. V., Ruiz, A. C., Ibáñez‐Pinilla, M., Pérez-Olmos, I., & Flórez, J. (2010). Experiencias de estigma en personas con enfermedad mental y su impacto en la autoestima en Colombia. reponame:Repositorio Institucional EdocUR.
564. Sánchez, M. J. R. (2016). Evaluación de la aceptabilidad y efectividad de un programa de telesalud por pacientes y profesionales para el tratamiento de la agorafobia.
565. Sönmez, D., Okumuş, B., & Hocaoğlu, Ç. (2021). The Occurrence of Funeral Mania After Bereavement: A Case Report. Medeniyet Medical Journal. https://doi.org/10.5222/mmj.2021.58998
566. Tacn, A. (2012). PTSD in the Context of Malignant Disease. InTech eBooks. https://doi.org/10.5772/27424
567. Teixeira, T. F. C. (2019). EROTOMANIA BORDERLINE OR PASSION WITHOUT BOUNDARIES?. https://doi.org/10.26226/morressier.5d1a036f57558b317a140026
568. Thach, B. T. (2003). The brainstem and vulnerability to sudden infant death syndrome. Neurology. https://doi.org/10.1212/wnl.61.9.1170
569. Thakur, A., Choudhary, D., Kumar, B., & Chaudhary, A. (2021). A Review on Post-traumatic Stress Disorder (PTSD): Symptoms, Therapies and Recent Case Studies. Current Molecular Pharmacology. https://doi.org/10.2174/1874467214666210525160944
570. Therrien, F., & Markowitz, J. S. (1997). Selective serotonin reuptake inhibitors and withdrawal symptoms: a review of the literature. Human Psychopharmacology Clinical and Experimental. https://doi.org/10.1002/(sici)1099-1077(199707/08)12:4<309::aid-hup855>3.0.co;2-a
571. Thiesen, S., Macdonald, A., Kinmond, S., & Ansary, A. (2021). 1657 Neonatal drug withdrawal from intrauterine exposure to antiemetics. Abstracts. https://doi.org/10.1136/archdischild-2021-rcpch.777
572. Todorović, S. (2016). Socijalno medicinske karakteristike i razlike između alkoholičara sa periodičnim i kontinuiranim pijenjem / Social and Medical Characteristics and Differences Between Alcoholics With Periodic and Continuous Drinking. SESTRINSKI ŽURNAL. https://doi.org/10.7251/sez0116005t
573. Tollefson, G. D., Rampey, A. H., Potvin, J. H., Jenike, M. A., Rush, A. J., Dominguez, R. A., Koran, L. M., Shear, M. K., Goodman, W. K., & Genduso, L. A. (2022). A Multicenter Investigation of Fixed-Dose Fluoxetine in the Treatment of Obsessive-compulsive Disorder. Routledge eBooks. https://doi.org/10.4324/9780203822937-24
574. Tondo, L., & Baldessarini, R. J. (2020). Discontinuing psychotropic drug treatment. BJPsych Open. https://doi.org/10.1192/bjo.2020.6
575. Torres, A. R., & Smaira, S. I. (2001). Quadro clínico do transtorno obsessivo-compulsivo. Brazilian Journal of Psychiatry. https://doi.org/10.1590/s1516-44462001000600003
576. Traub, R. D., Moeller, F., Rosch, R., Baldeweg, T., Whittington, M. A., & Hall, S. P. (2019). Seizure initiation in infantile spasms vs. focal seizures: proposed common cellular mechanisms. Reviews in the Neurosciences. https://doi.org/10.1515/revneuro-2019-0030
577. Trevisan, L., Boutros, N. N., Petrakis, I. L., & Krystal, J. H. (1998). Complications of alcohol withdrawal: pathophysiological insights.. PubMed.
578. Trill, M. D. (2012). Psychological aspects of depression in cancer patients: an update. Annals of Oncology. https://doi.org/10.1093/annonc/mds350
579. Trinka, E., Cock, H. R., Hesdorffer, D. C., Rossetti, A. O., Scheffer, I. E., Shinnar, S., Shorvon, S., & Lowenstein, D. H. (2015). A definition and classification of status epilepticus – Report of the<scp>ILAE</scp>Task Force on Classification of Status Epilepticus. Epilepsia. https://doi.org/10.1111/epi.13121
580. Trivedi, M. S., Hershman, D. L., & Crew, K. D. (2015). Management of Chemotherapy-Induced Peripheral Neuropathy. American Journal of Hematology / Oncology®.
581. Trujillo, K. A. (2012). The Role of NMDA Receptors in Opiate Tolerance, Sensitization, and Physical Dependence A Review of the Research, A Cellular Model, and Implications for the Treatment of Pain and Addiction.
582. Tso, I. F., Chun, J., & Deldin, P. J. (2010). Schizoaffective Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0818
583. Tugendhaft, P. (2004). [The follow-up of antiepileptic drugs].. PubMed.
584. Turganova, G., Lutoshliva, E. S., & Vorobyeva, E. N. (2018). Features of Depressed Mood of Cancer Patients at Different Stages of the Disease. Baikal Research Journal. https://doi.org/10.17150/2411-6262.2018.9(4).8
585. Twenge, J. M. (2011). Generational differences in mental health: Are children and adolescents suffering more, or less?. American Journal of Orthopsychiatry. https://doi.org/10.1111/j.1939-0025.2011.01115.x
586. Uher, R., & Pavlová, B. (2016). Long-term effects of depression treatment. The Lancet Psychiatry. https://doi.org/10.1016/s2215-0366(15)00578-7
587. Urban‐Kowalczyk, M., Rudecki, T., Wróblewski, D., & Rabe‐Jabłońska, J. (2012). [Psychotic disorders related with chronic use of mephedrone. Case report].. PubMed.
588. Uğurlu, G. K., Uğurlu, M., & Çayköylü, A. (2012). The emergence of obsessive compulsive and compulsive buying symptomatology after acute stress and short-term use of ribavirin: case reports. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125312467346
589. Valen, E. V., Hout, E. S. E. V., Wekking, E. M., Lenderink, A., Laan, G. V. D., & Hageman, G. (2015). Hersenschade door blootstelling aan oplosmiddelen; diagnostiek en beloop van chronische toxische encefalopathie.
590. Vanderschuren, L. J. M. J. (2008). Neurobehavioral Mechanisms of Compulsive Drug Seeking. https://doi.org/10.1093/oso/9780195300550.003.0009
591. Vargas, J. K. R. F. (1999). Artículos de Revisión.
592. Veale, D. (2004). Body dysmorphic disorder. Postgraduate Medical Journal. https://doi.org/10.1136/pmj.2003.015289
593. Vermetten, E., Krediet, E., Bostoen, T., Breeksema, J. J., Schoevers, R. A., & Brink, W. V. D. (2020). [Psychedelics in the treatment of PTSD].. PubMed.
594. Versino, M., Sances, G., Anghileri, E., Colnaghi, S., Albizzati, C., Bono, G., & Cosi, V. (2003). Dizziness and migraine: a causal relationship?. PubMed.
595. Vicente, J. F. M. (2014). Estado epiléptico refractario en el entorno de la terapia intensiva. Medicina Crítica.
596. Vicente, M. O., Gutiérrez, L. E. J. F., & Oves, M. I. R. (2011). ALCOHOLISMO CONSECUTIVO AL TRASTORNO DE PÁNICO. DOAJ (DOAJ: Directory of Open Access Journals).
597. Viv, A., & Aristides, V. (2012). Cognitive-Behavioral Therapy of Obsessive-Compulsive Disorder. InTech eBooks. https://doi.org/10.5772/30043
598. Vliet, I. M. V. (1999). [A hidden compulsion].. PubMed.
599. Volder, I. D. (2006). Periodic limb movement disorder and restless legs syndrome. Breathe. https://doi.org/10.1183/18106838.0203.250
600. Vægter, H. B. (2017). Exercising non-painful muscles can induce hypoalgesia in individuals with chronic pain. Scandinavian Journal of Pain. https://doi.org/10.1016/j.sjpain.2016.12.005
601. Wahyuni, A. A. S., WIGUNA, I. G. R. P., & Aditya, M. R. (2023). WAHAM SOMATIK : SEBUAH TINJAUAN PUSTAKA. Jurnal Hasil Penelitian dan Pengembangan (JHPP). https://doi.org/10.61116/jhpp.v1i3.156
602. Wakefield, J. C. (2015). DSM-5 substance use disorder: how conceptual missteps weakened the foundations of the addictive disorders field. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.12446
603. Wakefield, J. C., & Schmitz, M. F. (2014). Uncomplicated depression is normal sadness, not depressive disorder: further evidence from the NESARC. World Psychiatry. https://doi.org/10.1002/wps.20155
604. Walters, A. S., & Zee, P. C. (2023). Why the worsening at rest and worsening at night criteria for Restless Legs Syndrome are listed separately: review of the circadian literature on RLS and suggestions for future directions. Frontiers in Neurology. https://doi.org/10.3389/fneur.2023.1153273
605. Walther, M., & Woods, D. W. (2010). Trichotillomania. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy1011
606. Wand, G. S. (2008). The influence of stress on the transition from drug use to addiction.. PubMed.
607. Wang, M. (2015). Acupuncture as a Treatment Option in Treating Posttraumatic Stress Disorder– Related Tinnitus in War Veterans.
608. Weems, C. F. (2019). The importance of the post-disaster context in fostering human resilience. The Lancet Planetary Health. https://doi.org/10.1016/s2542-5196(19)30014-2
609. Weiss, B., Clarkson, T. W., & Simon, W. (2002). Silent latency periods in methylmercury poisoning and in neurodegenerative disease.. Environmental Health Perspectives. https://doi.org/10.1289/ehp.02110s5851
610. Weller, E. B., Weller, R. A., & Dogin, J. W. (1998). A rose is a rose is a rose. Journal of Affective Disorders. https://doi.org/10.1016/s0165-0327(98)00180-3
611. Welte-Santana, C., Nunes, F. T., Toledo, L. C. D., & Oliveira, L. P. (2016). Significant weight loss related to Briquet syndrome: A case report. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.2084
612. Wermelt, J. Z., & Ellerkmann, R. K. (2016). Emergence Delir - Prophylaxe und Therapie. AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. https://doi.org/10.1055/s-0041-106569
613. White, A. M., Williams, P. A., Hellier, J. L., Clark, S., Dudek, F. E., & Staley, K. J. (2009). EEG spike activity precedes epilepsy after kainate‐induced status epilepticus. Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02339.x
614. White, P. D. (2004). What causes chronic fatigue syndrome?. BMJ. https://doi.org/10.1136/bmj.329.7472.928
615. Whitfield, C. L. (1998). Internal evidence and corroboration of traumatic memories of child sexual abuse with addictive disorders. Sexual Health & Compulsivity. https://doi.org/10.1080/10720169808402337
616. Wiebe, D. J., Comstock, R. D., & Nance, M. L. (2011). Concussion research: a public health priority. Injury Prevention. https://doi.org/10.1136/ip.2010.031211
617. Wieland, C. (2008). Chronic and acute enactment: the passive therapist and the perverse transference. https://doi.org/10.4324/9780203891926-18
618. Williams, P. (2004). Incorporation of an invasive object. The International Journal of Psychoanalysis. https://doi.org/10.1516/0020757042683934
619. Williams, R. H., Erickson, T. B., & Broussard, L. A. (2000). Evaluating Sympathomimetic Intoxication in an Emergency Setting. Laboratory Medicine. https://doi.org/10.1309/wvx1-6fpv-e2lc-b6yg
620. Willner, P., Bergman, J., & Sanger, D. J. (2009). Behavioural pharmacology of impulse control. Behavioural Pharmacology. https://doi.org/10.1097/01.fbp.0000359407.60839.2d
621. Wing, J. K. (1998). The SCAN Glossary and principles of the interview. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511666445.005
622. Winkelman, J. W. (2009). The Diagnosis and Work-Up of Insomnia. CNS Spectrums. https://doi.org/10.1017/s1092852900003941
623. Winstock, A., & Schifano, F. (2012). Disorders relating to the use of ecstasy and other ‘party drugs’. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0066
624. Winters, K. C., & Ingwalson, A. (2022). Substance Use Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190678487.003.0005
625. Winters, W. D. (1976). Effects of Drugs on the Electrical Activity of the Brain: Anesthetics. The Annual Review of Pharmacology and Toxicology. https://doi.org/10.1146/annurev.pa.16.040176.002213
626. Wissow, L. S. (2021). Anxiety and Trauma-Related Distress. Pediatric Care Online. https://doi.org/10.1542/aap.ppcqr.396464
627. Wolf, C. J. H., Beurmanjer, H., Dijkstra, B., Geerlings, A. C., Spoelder, M., Homberg, J. R., & Schellekens, A. (2021). Characterization of the GHB Withdrawal Syndrome. Journal of Clinical Medicine. https://doi.org/10.3390/jcm10112333
628. Wolf, M. E. (2002). Addiction and Glutamate-Dependent Plasticity. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-306-4_8
629. Wolff, A., Vanduynhoven, E., Kleef, M. V., Huygen, F., Pope, J. E., & Mekhail, N. (2011). 21. Phantom Pain. Pain Practice. https://doi.org/10.1111/j.1533-2500.2011.00454.x
630. Wyatt, J. P., Illingworth, R. N., Graham, C. A., Hogg, K., Clancy, M., & Robertson, C. E. (2012). Environmental emergencies. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199589562.003.0006
631. Wyman, J. F. (1998). Quality of Life of Older Adults with Urinary Incontinence. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.1998.tb03816.x
632. Yates, S. J., Ahuja, N., Gartside, S. E., & McAllister‐Williams, R. H. (2011). Serotonin syndrome following introduction of venlafaxine following withdrawal of phenelzine: implications for drug washout periods. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125311413497
633. Yetkın, S., & Çor, S. A. (2023). Psychological Inflexibility in Depression with Psychotic Features: A Case Report. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.2180
634. Yilmaz, A., Bozkurt, M., & Evren, C. (2014). Alkol ve Madde Bağimliliğinda Remisyon ve Depreşme Remission and Relapse in Alcohol and Substance Addiction.
635. Young, W. B., Packard, R. C., & Katsarava, Z. (2007). Headaches Associated with Head Trauma. https://doi.org/10.1093/oso/9780195326567.003.0016
636. Yui, K., Kajii, Y., & Nishikawa, T. (2006). Neurobiological and Molecular Bases of Methamphetamine-Induced Behavioral Sensitization and Spontaneous Recurrence of Methamphetamine Psychosis, and its Implication in Schizophrenia. Current Psychiatry Reviews. https://doi.org/10.2174/157340006778018111
637. Zandara, M. (2017). Effect of psychosocial stress on cognitive processing and non-verbal behavior: the role of the autonomic nervous system and the hypothalamic-pituitary-adrenal axis. Antecedents and consequences of psychological and physiological stress in a group of healthy young adults.
638. Zeller, J. L., Burke, A. E., & Glass, R. M. (2008). Acute Pain Treatment. JAMA. https://doi.org/10.1001/jama.299.1.128
639. Zhang, K., & Hashimoto, K. (2018). An update on ketamine and its two enantiomers as rapid-acting antidepressants. Expert Review of Neurotherapeutics. https://doi.org/10.1080/14737175.2019.1554434
640. Zutshi, A., Math, S. B., & Reddy, Y. C. J. (2007). Escitalopram in Obsessive-Compulsive Disorder. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611c
641. Ďurdík, P., Olek, F., ov, U. J., an, T. T., & Bánovčin, P. (2020). Young and exhausted. Authorea (Authorea). https://doi.org/10.22541/au.159294140.04360533